{"title":"Catalog","description":null,"products":[{"product_id":"retatrutide-20-mg","title":"Retatrutide","description":"\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:0 0 .4em;font-family:inherit;\"\u003eWhat it is\u003c\/p\u003e\n\u003cp style=\"font-size:1.12em;line-height:1.7;margin:0 0 1em;\"\u003eThe most potent metabolic peptide in the literature today. It acts \u003cstrong\u003eon three switches at once\u003c\/strong\u003e for appetite and energy expenditure, instead of on just one like earlier-generation compounds.\u003c\/p\u003e\n\u003cp style=\"font-size:1.02em;line-height:1.7;margin:0 0 1.2em;color:#374151;\"\u003eYour body has several hormones that tell the brain “that's enough, stop eating.” Retatrutide mimics three of them simultaneously. The first two reduce hunger; the third also makes the body burn more. That is why the published figures are higher than those of any other compound in its family.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eWhat it is used for\u003c\/p\u003e\n\u003cul style=\"margin:0 0 1.2em;padding-left:0;list-style:none;line-height:1.9;\"\u003e\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Research on body weight and appetite control\u003c\/li\u003e\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Body recomposition studies: how much fat is lost and how much muscle is preserved\u003c\/li\u003e\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Energy expenditure: the branch that sets it apart from the rest\u003c\/li\u003e\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Fatty liver and blood sugar control\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eHow it is used\u003c\/p\u003e\n\u003cdiv style=\"display:flex;gap:12px;margin:0 0 1.4em;flex-wrap:wrap;\"\u003e\n  \u003cdiv style=\"flex:1;min-width:150px;padding:12px 16px;background:#f6f6f7;border-radius:10px;\"\u003e\n    \u003cdiv style=\"font-size:.72em;text-transform:uppercase;letter-spacing:.08em;color:#9ca3af;margin-bottom:2px;\"\u003eCycle\u003c\/div\u003e\n    \u003cdiv style=\"font-weight:600;\"\u003eContinuous until target\u003c\/div\u003e\n  \u003c\/div\u003e\n  \u003cdiv style=\"flex:1;min-width:150px;padding:12px 16px;background:#f6f6f7;border-radius:10px;\"\u003e\n    \u003cdiv style=\"font-size:.72em;text-transform:uppercase;letter-spacing:.08em;color:#9ca3af;margin-bottom:2px;\"\u003eBreak\u003c\/div\u003e\n    \u003cdiv style=\"font-weight:600;\"\u003eNot required\u003c\/div\u003e\n  \u003c\/div\u003e\n  \u003cdiv style=\"flex:1;min-width:150px;padding:12px 16px;background:#f6f6f7;border-radius:10px;\"\u003e\n    \u003cdiv style=\"font-size:.72em;text-transform:uppercase;letter-spacing:.08em;color:#9ca3af;margin-bottom:2px;\"\u003eRoute\u003c\/div\u003e\n    \u003cdiv style=\"font-weight:600;\"\u003eWeekly subcutaneous\u003c\/div\u003e\n  \u003c\/div\u003e\n\u003c\/div\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eLyophilized powder. It is reconstituted with bacteriostatic water, swirled without shaking until dissolved, and stored between 2 and 8 °C. In the literature it is administered once a week, always with gradual dose escalation: increasing slowly is what reduces digestive discomfort \u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[1]\u003c\/sup\u003e.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eWhat has been observed\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;color:#6b7280;font-size:.95em;\"\u003eResults described in the published scientific literature. They are not directions for use or health recommendations.\u003c\/p\u003e\n\u003cul style=\"margin:0 0 1.2em;padding-left:0;list-style:none;line-height:1.9;\"\u003e\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  In the phase 2 trial (338 adults, 48 weeks), the 12 mg dose produced a mean body weight reduction of \u003cstrong\u003e24.2%\u003c\/strong\u003e, versus 2.1% with placebo \u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[1]\u003c\/sup\u003e\n\u003c\/li\u003e\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  At 8 mg, 100% of participants lost at least 5% of their weight, 91% at least 10%, and 75% at least 15% \u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[1]\u003c\/sup\u003e\n\u003c\/li\u003e\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  A phase 2a trial in metabolic fatty liver disease described significant reductions in liver fat content \u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[2]\u003c\/sup\u003e\n\u003c\/li\u003e\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Digestive effects were the most frequent: they were dose-dependent, mostly mild or moderate, and were attenuated by starting with a lower initial dose \u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[1]\u003c\/sup\u003e\n\u003c\/li\u003e\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  A dose-dependent increase in heart rate was observed, peaking at 24 weeks and declining thereafter \u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[1]\u003c\/sup\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eHow it works\u003c\/p\u003e\n\u003cp style=\"margin:1.1em 0 0.3em;font-weight:600;font-family:inherit;\"\u003eGIP \/ GLP-1 \/ glucagon triple agonism\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eRetatrutide (LY-3437943) acts as an agonist of the glucose-dependent insulinotropic polypeptide, glucagon-like peptide-1 and glucagon receptors \u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[1]\u003c\/sup\u003e. The first two branches reduce intake centrally and slow gastric emptying.\u003c\/p\u003e\n\u003cp style=\"margin:1.1em 0 0.3em;font-weight:600;font-family:inherit;\"\u003eThe glucagon branch\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eThis is what sets it apart from dual agonists. Signaling through the glucagon receptor is associated with increased energy expenditure and mobilization of liver fat, so energy balance is addressed from both sides: less in and more out \u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[2]\u003c\/sup\u003e\u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[4]\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp style=\"margin:1.1em 0 0.3em;font-weight:600;font-family:inherit;\"\u003eClinical development\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eIt has completed phase 2 in obesity and in metabolic dysfunction-associated steatotic liver disease, and is in registrational phase 3 in obesity, sleep apnea and knee osteoarthritis, as well as type 2 diabetes \u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[2]\u003c\/sup\u003e\u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[3]\u003c\/sup\u003e.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eState of the evidence\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.7em;padding:10px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e\u003cstrong\u003eClinical and top-tier.\u003c\/strong\u003e The data come from randomized, placebo-controlled clinical trials published in \u003cem\u003eThe New England Journal of Medicine\u003c\/em\u003e, \u003cem\u003eNature Medicine\u003c\/em\u003e and \u003cem\u003eThe Lancet\u003c\/em\u003e \u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[1]\u003c\/sup\u003e\u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[2]\u003c\/sup\u003e\u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[3]\u003c\/sup\u003e. One distinction is worth keeping in mind: those clinical trials were conducted with a pharmaceutical product in patients and under medical supervision. What we offer here is reference material for research, not an approved medicine.\u003c\/p\u003e\n\n\u003cp style=\"margin:1.6em 0 0;padding:12px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e⚠️ Product intended exclusively for \u003cstrong\u003eresearch and laboratory use\u003c\/strong\u003e. Not for human or veterinary consumption.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eReferences\u003c\/p\u003e\n\u003col style=\"margin:0;padding-left:1.4em;font-size:.86em;color:#6b7280;line-height:1.7;\"\u003e\n  \u003cli\u003eJastreboff AM, et al. \u003cem\u003eTriple-Hormone-Receptor Agonist Retatrutide for Obesity - A Phase 2 Trial.\u003c\/em\u003e N Engl J Med, 2023. \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/37366315\/\" target=\"_blank\" rel=\"nofollow noopener\" style=\"color:#0099ff;text-decoration:none;\"\u003ePubMed 37366315\u003c\/a\u003e\n\u003c\/li\u003e\n  \u003cli\u003eSanyal AJ, et al. \u003cem\u003eTriple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial.\u003c\/em\u003e Nat Med, 2024. \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38858523\/\" target=\"_blank\" rel=\"nofollow noopener\" style=\"color:#0099ff;text-decoration:none;\"\u003ePubMed 38858523\u003c\/a\u003e\n\u003c\/li\u003e\n  \u003cli\u003eBajaj HS, et al. \u003cem\u003eEfficacy and safety of retatrutide, a GIP, GLP-1, and glucagon receptor agonist, in people with type 2 diabetes (TRANSCEND-T2D-1): a phase 3 trial.\u003c\/em\u003e Lancet, 2026. \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/42250575\/\" target=\"_blank\" rel=\"nofollow noopener\" style=\"color:#0099ff;text-decoration:none;\"\u003ePubMed 42250575\u003c\/a\u003e\n\u003c\/li\u003e\n  \u003cli\u003eKatsi V, et al. \u003cem\u003eRetatrutide — A Game Changer in Obesity Pharmacotherapy.\u003c\/em\u003e Biomolecules, 2025. \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40563436\/\" target=\"_blank\" rel=\"nofollow noopener\" style=\"color:#0099ff;text-decoration:none;\"\u003ePubMed 40563436\u003c\/a\u003e\n\u003c\/li\u003e\n\u003c\/ol\u003e","brand":"PeptidoBioGenetic","offers":[{"title":"15 mg","offer_id":54603479646537,"sku":"RT15","price":197.9,"currency_code":"EUR","in_stock":false},{"title":"20 mg","offer_id":54603479679305,"sku":"RT20","price":241.9,"currency_code":"EUR","in_stock":true},{"title":"30 mg","offer_id":54760619049289,"sku":"RT30","price":289.9,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1016\/7507\/3865\/files\/principal-sin-fondo-removebg-preview.png?v=1782817358"},{"product_id":"ghk-cu-50-mg","title":"GHK Cu","description":"\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:0 0 .4em;font-family:inherit;\"\u003eSummary\u003c\/p\u003e\n\u003cp style=\"font-size:1.05em;line-height:1.65;margin:0 0 1.2em;\"\u003e\u003cstrong\u003eGHK-Cu\u003c\/strong\u003e is investigated for its role in \u003cstrong\u003ecollagen and elastin, wound healing, and skin firmness and health\u003c\/strong\u003e. Technically, it is the copper(II) complex of the tripeptide glycyl-L-histidyl-L-lysine, an endogenous molecule naturally present in human plasma, saliva, and urine, which transports copper into the cell and acts as a regenerative modulator, antioxidant, and anti-inflammatory even at nanomolar concentrations. It is probably the most studied copper peptide in regenerative biology.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eWhat is it investigated for?\u003c\/p\u003e\n\u003cul style=\"margin:0 0 1.2em;padding-left:0;list-style:none;line-height:1.9;\"\u003e\n\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Collagen and elastin synthesis\u003c\/li\u003e\n\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Skin healing and firmness\u003c\/li\u003e\n\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Antioxidant and anti-inflammatory defense\u003c\/li\u003e\n\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Angiogenesis and extracellular matrix remodeling\u003c\/li\u003e\n\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Epigenetic regulation of gene expression\u003c\/li\u003e\n\n\n\u003c\/ul\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eCycle \u0026amp; Break\u003c\/p\u003e\n\u003cdiv style=\"display:flex;gap:12px;margin:0 0 1.4em;flex-wrap:wrap;\"\u003e\n\n  \u003cdiv style=\"flex:1;min-width:150px;padding:12px 16px;background:#f6f6f7;border-radius:10px;\"\u003e\n\n    \u003cdiv style=\"font-size:.72em;text-transform:uppercase;letter-spacing:.08em;color:#9ca3af;margin-bottom:2px;\"\u003eCycle\u003c\/div\u003e\n\n    \u003cdiv style=\"font-weight:600;\"\u003e4–6 weeks\u003c\/div\u003e\n\n  \u003c\/div\u003e\n\n  \u003cdiv style=\"flex:1;min-width:150px;padding:12px 16px;background:#f6f6f7;border-radius:10px;\"\u003e\n\n    \u003cdiv style=\"font-size:.72em;text-transform:uppercase;letter-spacing:.08em;color:#9ca3af;margin-bottom:2px;\"\u003eBreak\u003c\/div\u003e\n\n    \u003cdiv style=\"font-weight:600;\"\u003e4 weeks\u003c\/div\u003e\n\n  \u003c\/div\u003e\n\n\n\u003c\/div\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eMechanism of Action\u003c\/p\u003e\n\u003cp style=\"margin:1.1em 0 0.3em;font-weight:600;font-family:inherit;\"\u003eExtracellular Matrix Regeneration and Collagen Synthesis\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eGHK-Cu activates dermal fibroblasts—the connective tissue cells that produce the extracellular matrix (ECM)—and drives its remodeling. Through the TGF-β signaling pathway, it upregulates type I collagen, elastin, and glycosaminoglycan expression while adjusting the balance between metalloproteinases (MMP1, MMP2) and their tissue inhibitors (TIMP1, TIMP2) to prevent excessive tissue degradation. In wound healing models, collagen synthesis increases by \u003cstrong\u003e70% to 230%\u003c\/strong\u003e, reaching up to nine times in in vitro assays with fibroblasts.\u003c\/p\u003e\n\u003cp style=\"margin:1.1em 0 0.3em;font-weight:600;font-family:inherit;\"\u003eAntioxidant and Anti-inflammatory Action\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eIt provides bioavailable copper to the enzyme Cu,Zn-SOD1, mimicking superoxide dismutase activity and reducing reactive oxygen species (ROS) such as superoxide and hydroxyl radicals. Additionally, it limits iron release from ferritin (up to 87% inhibition), decreases lipid peroxidation byproducts, and protects against LDL oxidation. On the anti-inflammatory front, it suppresses NF-κB (p65) and p38 MAPK pathways, leading to a reduction in mediators such as TNF-α, IL-6, and fibrinogen.\u003c\/p\u003e\n\u003cp style=\"margin:1.1em 0 0.3em;font-weight:600;font-family:inherit;\"\u003eStimulation of Angiogenesis\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eIt promotes the formation of new blood vessels by increasing VEGF and bFGF (FGF2) secretion by fibroblasts and mesenchymal stem cells. Released from the SPARC protein during tissue injury, it promotes endothelial proliferation in early repair phases and moderates it in later phases.\u003c\/p\u003e\n\u003cp style=\"margin:1.1em 0 0.3em;font-weight:600;font-family:inherit;\"\u003eEpigenetic Modulation of Gene Expression\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eGHK-Cu modifies the expression of more than \u003cstrong\u003e1,000 genes\u003c\/strong\u003e—approximately 1,569 upregulated and 583 downregulated—acting as an epigenetic regulator by inhibiting histone deacetylases (HDACs). This reactivates regenerative pathways (TGF-β, integrins, p63) while attenuating gene programs associated with inflammation and tumor processes.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eScientific Evidence\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.7em;padding:10px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e\u003cstrong\u003eCollagen and Matrix:\u003c\/strong\u003e In vitro studies in fibroblasts and rat wound models document collagen increases of up to 9×, with gene profiles confirming TGF-β pathway activation.\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.7em;padding:10px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e\u003cstrong\u003eAntioxidant and Anti-inflammatory:\u003c\/strong\u003e UV radiation protection assays in keratinocytes and fibroblast cultures show cytokine decreases; animal models confirm ROS neutralization.\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.7em;padding:10px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e\u003cstrong\u003eAngiogenesis:\u003c\/strong\u003e Gene data reflects a \u003cstrong\u003e487% increase in ANGPT1 expression\u003c\/strong\u003e; studies in rabbit wounds show greater granulation tissue and vascularization.\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.7em;padding:10px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e\u003cstrong\u003eGene Regulation:\u003c\/strong\u003e Microarray analyses (e.g., Connectivity Map) show broad effects; in COPD models, the reversal of 127 genes towards a healthier profile has been described.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eProduct Use\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eDue to this comprehensive profile, GHK-Cu is a key peptide in research lines on tissue regeneration and wound healing, extracellular matrix and collagen biology, antioxidant defense, and hair follicle signaling. At \u003cstrong\u003ePeptido BioGenetic\u003c\/strong\u003e, we supply it as high-purity material for laboratory use, with a Certificate of Analysis (COA) available upon request.\u003c\/p\u003e\n\n\u003cp style=\"margin:1.6em 0 0;padding:12px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e⚠️ Product intended exclusively for \u003cstrong\u003eresearch and laboratory use\u003c\/strong\u003e. Not for human or veterinary consumption.\u003c\/p\u003e","brand":"PeptidoBioGenetic","offers":[{"title":"100 mg","offer_id":54603479712073,"sku":"CU100","price":176.9,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1016\/7507\/3865\/files\/ghk-cu-50-mg-sin-fondo.png?v=1782825071"},{"product_id":"semax-10-mg","title":"SEMAX","description":"\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:0 0 .4em;font-family:inherit;\"\u003eSummary\u003c\/p\u003e\n\u003cp style=\"font-size:1.05em;line-height:1.65;margin:0 0 1.2em;\"\u003e\u003cstrong\u003eSemax\u003c\/strong\u003e is one of the most studied nootropics in the \u003cstrong\u003eneurocognitive\u003c\/strong\u003e field: it is investigated for its role in \u003cstrong\u003ecognitive function, memory, and neuroprotection\u003c\/strong\u003e. Technically, it is a synthetic neuropeptide (Met-Glu-His-Phe-Pro-Gly-Pro) derived from a modified fragment of ACTH(4-10), stabilized with the tripeptide Pro-Gly-Pro to resist enzymatic degradation, and is registered in Russia as a nootropic and neuroprotective drug.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eWhat is it being investigated for?\u003c\/p\u003e\n\u003cul style=\"margin:0 0 1.2em;padding-left:0;list-style:none;line-height:1.9;\"\u003e\n\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Cognitive function and working memory\u003c\/li\u003e\n\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Synaptic plasticity and learning\u003c\/li\u003e\n\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Neuroprotection against oxidative stress\u003c\/li\u003e\n\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Modulation of neurotransmission\u003c\/li\u003e\n\n\n\u003c\/ul\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eCycle and break\u003c\/p\u003e\n\u003cdiv style=\"display:flex;gap:12px;margin:0 0 1.4em;flex-wrap:wrap;\"\u003e\n\n  \u003cdiv style=\"flex:1;min-width:150px;padding:12px 16px;background:#f6f6f7;border-radius:10px;\"\u003e\n\n    \u003cdiv style=\"font-size:.72em;text-transform:uppercase;letter-spacing:.08em;color:#9ca3af;margin-bottom:2px;\"\u003eCycle\u003c\/div\u003e\n\n    \u003cdiv style=\"font-weight:600;\"\u003e7–14 days\u003c\/div\u003e\n\n  \u003c\/div\u003e\n\n  \u003cdiv style=\"flex:1;min-width:150px;padding:12px 16px;background:#f6f6f7;border-radius:10px;\"\u003e\n\n    \u003cdiv style=\"font-size:.72em;text-transform:uppercase;letter-spacing:.08em;color:#9ca3af;margin-bottom:2px;\"\u003eBreak\u003c\/div\u003e\n\n    \u003cdiv style=\"font-weight:600;\"\u003e1–2 weeks\u003c\/div\u003e\n\n  \u003c\/div\u003e\n\n\n\u003c\/div\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eMechanism of action\u003c\/p\u003e\n\u003cp style=\"margin:1.1em 0 0.3em;font-weight:600;font-family:inherit;\"\u003eNeurotrophic signaling (BDNF\/TrkB)\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eOne of its most notable findings is the rapid induction of brain-derived neurotrophic factor (BDNF) and activation of the TrkB receptor, central mechanisms of synaptic plasticity, memory, and neuronal survival.\u003c\/p\u003e\n\u003cp style=\"margin:1.1em 0 0.3em;font-weight:600;font-family:inherit;\"\u003eNeurotransmission and neuroprotection\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eIt modulates dopaminergic and serotonergic systems and melanocortin receptors (MC4, MC5), and inhibits the degradation of endogenous enkephalins, prolonging their neuromodulatory effect.\u003c\/p\u003e\n\u003cp style=\"margin:1.1em 0 0.3em;font-weight:600;font-family:inherit;\"\u003eAntioxidation and gene expression\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eIt regulates genes linked to oxidative stress and forms complexes with copper ions (Cu²⁺), which reinforces its neuroprotective profile.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eScientific evidence\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.7em;padding:10px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e\u003cstrong\u003eBDNF\/TrkB:\u003c\/strong\u003e Studies in rodent hippocampus describe an increase in BDNF and its mRNA expression 30-90 minutes after administration (Dolotov et al.), with sustained activation of the TrkB pathway.\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.7em;padding:10px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e\u003cstrong\u003eNeuroprotection:\u003c\/strong\u003e In cerebral ischemia models, it has been associated with reduced neuronal damage; in Russia, it is clinically used in the acute phase of stroke and in cognitive disorders.\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.7em;padding:10px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e\u003cstrong\u003eAntioxidation:\u003c\/strong\u003e Assays in neuronal cultures show a reduction in oxidative stress markers.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eProduct use\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eDue to its rapid effect on BDNF and its neuroprotective profile validated in clinical use, Semax is a reference peptide in cognition, memory, and neuroprotection research. At \u003cstrong\u003ePeptido BioGenetic\u003c\/strong\u003e, we supply it as a high-purity peptide for laboratory use, with a certificate of analysis (COA) available upon request.\u003c\/p\u003e\n\n\u003cp style=\"margin:1.6em 0 0;padding:12px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e⚠️ Product intended exclusively for \u003cstrong\u003eresearch and laboratory use\u003c\/strong\u003e. Not suitable for human or veterinary consumption.\u003c\/p\u003e","brand":"PeptidoBioGenetic","offers":[{"title":"10 mg","offer_id":54545811276105,"sku":"XA10","price":82.9,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1016\/7507\/3865\/files\/semax-10-mg-sin-fondo.png?v=1782819708"},{"product_id":"klow-blend-80-mg","title":"KLOW","description":"\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:0 0 .4em;font-family:inherit;\"\u003eSummary\u003c\/p\u003e\n\u003cp style=\"font-size:1.05em;line-height:1.65;margin:0 0 1.2em;\"\u003eThe \u003cstrong\u003eKLOW\u003c\/strong\u003e blend is investigated for its role in \u003cstrong\u003etissue repair, inflammation, and cell vitality\u003c\/strong\u003e. It brings together four of the most studied regenerative peptides in a single vial—\u003cstrong\u003eBPC-157\u003c\/strong\u003e, \u003cstrong\u003eGHK-Cu\u003c\/strong\u003e, \u003cstrong\u003eTB-500\u003c\/strong\u003e (Tβ4), and \u003cstrong\u003eKPV\u003c\/strong\u003e—designed for combined research into cytoprotection, extracellular matrix remodeling, and inflammation modulation.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eWhat is it investigated for?\u003c\/p\u003e\n\u003cul style=\"margin:0 0 1.2em;padding-left:0;list-style:none;line-height:1.9;\"\u003e\n\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Comprehensive tissue repair\u003c\/li\u003e\n\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Inflammation modulation\u003c\/li\u003e\n\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Extracellular matrix and collagen remodeling\u003c\/li\u003e\n\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Cytoprotection and cell vitality\u003c\/li\u003e\n\n\n\u003c\/ul\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eCycle and rest\u003c\/p\u003e\n\u003cdiv style=\"display:flex;gap:12px;margin:0 0 1.4em;flex-wrap:wrap;\"\u003e\n\n  \u003cdiv style=\"flex:1;min-width:150px;padding:12px 16px;background:#f6f6f7;border-radius:10px;\"\u003e\n\n    \u003cdiv style=\"font-size:.72em;text-transform:uppercase;letter-spacing:.08em;color:#9ca3af;margin-bottom:2px;\"\u003eCycle\u003c\/div\u003e\n\n    \u003cdiv style=\"font-weight:600;\"\u003e20–30 days\u003c\/div\u003e\n\n  \u003c\/div\u003e\n\n  \u003cdiv style=\"flex:1;min-width:150px;padding:12px 16px;background:#f6f6f7;border-radius:10px;\"\u003e\n\n    \u003cdiv style=\"font-size:.72em;text-transform:uppercase;letter-spacing:.08em;color:#9ca3af;margin-bottom:2px;\"\u003eRest\u003c\/div\u003e\n\n    \u003cdiv style=\"font-weight:600;\"\u003e3–4 months\u003c\/div\u003e\n\n  \u003c\/div\u003e\n\n\n\u003c\/div\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eMechanism of action\u003c\/p\u003e\n\u003cp style=\"margin:1.1em 0 0.3em;font-weight:600;font-family:inherit;\"\u003eBPC-157 — Cytoprotective signaling\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003ePentadecapeptide derived from a gastric protein, studied for its potent cytoprotective and angiogenic activity through the VEGFR2, PI3K-Akt-eNOS, and ERK1\/2 pathways.\u003c\/p\u003e\n\u003cp style=\"margin:1.1em 0 0.3em;font-weight:600;font-family:inherit;\"\u003eGHK-Cu and TB-500 — Matrix and cytoskeleton\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eGHK-Cu upregulates extracellular matrix (collagen, elastin) and antioxidant defense genes; TB-500 reorganizes actin and directs cell migration. Together, they cover two pillars of tissue repair.\u003c\/p\u003e\n\u003cp style=\"margin:1.1em 0 0.3em;font-weight:600;font-family:inherit;\"\u003eKPV — Inflammation brake\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eTripeptide derived from α-MSH that modulates NF-κB and MAPK pathways, with a marked anti-inflammatory effect at mucosal and systemic levels.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eScientific evidence\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.7em;padding:10px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e\u003cstrong\u003eBPC-157:\u003c\/strong\u003e numerous animal models describe accelerated healing of tendons, muscles, bones, and intestines.\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.7em;padding:10px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e\u003cstrong\u003eGHK-Cu and TB-500:\u003c\/strong\u003e GHK-Cu increases collagen synthesis by 70-230% in wound models; Tβ4 has reached clinical trials for wound healing.\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.7em;padding:10px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e\u003cstrong\u003eKPV:\u003c\/strong\u003e preclinical studies in colitis models show reduced inflammation. Honest note: human data for each component is limited, and there are no controlled studies of the combined formulation.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eProduct use\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eThe KLOW blend concentrates four complementary repair mechanisms into a single reference material for in vitro and laboratory research. At \u003cstrong\u003ePeptido BioGenetic\u003c\/strong\u003e, we offer it with high-purity components and a Certificate of Analysis (COA) available upon request.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eAdministration\u003c\/p\u003e\n\u003cdiv style=\"display:flex;gap:12px;margin:0 0 1em;flex-wrap:wrap;\"\u003e\n\n  \u003cdiv style=\"flex:1;min-width:150px;padding:12px 16px;background:#f6f6f7;border-radius:10px;\"\u003e\n\n\u003cdiv style=\"font-size:.72em;text-transform:uppercase;letter-spacing:.08em;color:#9ca3af;margin-bottom:2px;\"\u003eTiming\u003c\/div\u003e\n\n\u003cdiv style=\"font-weight:600;\"\u003eNight \/ post-workout\u003c\/div\u003e\n\n\n\u003c\/div\u003e\n\n  \u003cdiv style=\"flex:1;min-width:150px;padding:12px 16px;background:#f6f6f7;border-radius:10px;\"\u003e\n\n\u003cdiv style=\"font-size:.72em;text-transform:uppercase;letter-spacing:.08em;color:#9ca3af;margin-bottom:2px;\"\u003eApplication\u003c\/div\u003e\n\n\u003cdiv style=\"font-weight:600;\"\u003e1 single dose\u003c\/div\u003e\n\n\n\u003c\/div\u003e\n\n\n\u003c\/div\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eA single application, no multiple injections. Designed for easy administration.\u003c\/p\u003e\n\n\u003cp style=\"margin:1.6em 0 0;padding:12px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e⚠️ Product exclusively for \u003cstrong\u003eresearch and laboratory use\u003c\/strong\u003e. Not suitable for human or veterinary consumption.\u003c\/p\u003e","brand":"PeptidoBioGenetic","offers":[{"title":"80 mg","offer_id":54545811374409,"sku":"KLOW80","price":198.9,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1016\/7507\/3865\/files\/klow-blend-80-mg-sin-fondo.png?v=1782819714"},{"product_id":"epithalon-25-mg","title":"EPITHALON","description":"\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:0 0 .4em;font-family:inherit;\"\u003eSummary\u003c\/p\u003e\n\u003cp style=\"font-size:1.05em;line-height:1.65;margin:0 0 1.2em;\"\u003e\u003cstrong\u003eEpithalon\u003c\/strong\u003e is one of the benchmark peptides in research on \u003cstrong\u003elongevity and cellular aging\u003c\/strong\u003e. It is studied for its role in cellular repair, sleep rhythm, and telomere maintenance. Technically, it is a bioregulatory tetrapeptide (sequence AEDG: Ala-Glu-Asp-Gly) derived from pineal gland epithalamin, and one of the few peptides with direct evidence of telomerase activation in human cells.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eWhat is it researched for?\u003c\/p\u003e\n\u003cul style=\"margin:0 0 1.2em;padding-left:0;list-style:none;line-height:1.9;\"\u003e\n\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Telomerase activation and telomere maintenance\u003c\/li\u003e\n\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Cellular repair and senescence\u003c\/li\u003e\n\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Circadian rhythm and pineal sleep signaling\u003c\/li\u003e\n\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Antioxidant defense\u003c\/li\u003e\n\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Genomic stability and longevity\u003c\/li\u003e\n\n\n\u003c\/ul\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eCycle and rest\u003c\/p\u003e\n\u003cdiv style=\"display:flex;gap:12px;margin:0 0 1.4em;flex-wrap:wrap;\"\u003e\n\n  \u003cdiv style=\"flex:1;min-width:150px;padding:12px 16px;background:#f6f6f7;border-radius:10px;\"\u003e\n\n    \u003cdiv style=\"font-size:.72em;text-transform:uppercase;letter-spacing:.08em;color:#9ca3af;margin-bottom:2px;\"\u003eCycle\u003c\/div\u003e\n\n    \u003cdiv style=\"font-weight:600;\"\u003e10–20 days\u003c\/div\u003e\n\n  \u003c\/div\u003e\n\n  \u003cdiv style=\"flex:1;min-width:150px;padding:12px 16px;background:#f6f6f7;border-radius:10px;\"\u003e\n\n    \u003cdiv style=\"font-size:.72em;text-transform:uppercase;letter-spacing:.08em;color:#9ca3af;margin-bottom:2px;\"\u003eRest\u003c\/div\u003e\n\n    \u003cdiv style=\"font-weight:600;\"\u003e4–6 months\u003c\/div\u003e\n\n  \u003c\/div\u003e\n\n\n\u003c\/div\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eMechanism of action\u003c\/p\u003e\n\u003cp style=\"margin:1.1em 0 0.3em;font-weight:600;font-family:inherit;\"\u003eTelomerase and telomere maintenance\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eIt activates the telomerase enzyme, responsible for rebuilding telomeres (the protective ends of chromosomes that shorten with age), counteracting one of the central markers of cellular aging.\u003c\/p\u003e\n\u003cp style=\"margin:1.1em 0 0.3em;font-weight:600;font-family:inherit;\"\u003eCircadian rhythm and antioxidation\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eIt restores pineal signaling (melatonin and serotonin synthesis) and the regularity of the circadian rhythm, and enhances antioxidant defense by reducing reactive oxygen species.\u003c\/p\u003e\n\u003cp style=\"margin:1.1em 0 0.3em;font-weight:600;font-family:inherit;\"\u003eLongevity and genomic stability\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eIt regulates chromatin condensation states, T-lymphocyte maturation, and genome stability.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eScientific evidence\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.7em;padding:10px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e\u003cstrong\u003eTelomerase:\u003c\/strong\u003e In Prof. Khavinson's work, Epithalon activated telomerase and lengthened telomeres in cultured human fibroblasts, surpassing the Hayflick limit of cell divisions.\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.7em;padding:10px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e\u003cstrong\u003eCircadian rhythm:\u003c\/strong\u003e Animal models describe normalization of nocturnal melatonin and antioxidant enzymes in aged organisms.\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.7em;padding:10px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e\u003cstrong\u003eLongevity:\u003c\/strong\u003e Studies in rodents associated pineal peptides with increased life expectancy and lower tumor incidence; also investigated in Drosophila, primates, and human cultures.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eProduct use\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eDue to its demonstrated ability to activate telomerase, Epithalon is a first-rate reference material in senescence and longevity research. At \u003cstrong\u003ePeptido BioGenetic\u003c\/strong\u003e, we offer it as a high-purity peptide for laboratory use, with a Certificate of Analysis (COA) available upon request.\u003c\/p\u003e\n\n\u003cp style=\"margin:1.6em 0 0;padding:12px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e⚠️ Product intended exclusively for \u003cstrong\u003eresearch and laboratory use\u003c\/strong\u003e. Not suitable for human or veterinary consumption.\u003c\/p\u003e","brand":"PeptidoBioGenetic","offers":[{"title":"10 mg","offer_id":54545811439945,"sku":"ET10","price":78.9,"currency_code":"EUR","in_stock":false},{"title":"50 mg","offer_id":54603273863497,"sku":"ET50","price":143.9,"currency_code":"EUR","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1016\/7507\/3865\/files\/epithalon-25-mg-sin-fondo.png?v=1782819718"},{"product_id":"dsip-5-mg","title":"DSIP","description":"\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:0 0 .4em;font-family:inherit;\"\u003eSummary\u003c\/p\u003e\n\u003cp style=\"font-size:1.05em;line-height:1.65;margin:0 0 1.2em;\"\u003e\u003cstrong\u003eDSIP\u003c\/strong\u003e is one of the reference neuropeptides in the field of \u003cstrong\u003esleep, circadian rhythm, and stress\u003c\/strong\u003e: it is researched for its direct relationship with \u003cstrong\u003edeep sleep architecture\u003c\/strong\u003e. Technically, it is a natural nonapeptide (Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu) isolated in 1977 from the cerebral blood of sleeping rabbits.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eWhat is it researched for?\u003c\/p\u003e\n\u003cul style=\"margin:0 0 1.2em;padding-left:0;list-style:none;line-height:1.9;\"\u003e\n\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Deep delta wave sleep\u003c\/li\u003e\n\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Circadian rhythm and sleep-wake cycle\u003c\/li\u003e\n\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Stress response and neuroendocrine axis\u003c\/li\u003e\n\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Central antioxidant defense\u003c\/li\u003e\n\n\n\u003c\/ul\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eCycle and Rest\u003c\/p\u003e\n\u003cdiv style=\"display:flex;gap:12px;margin:0 0 1.4em;flex-wrap:wrap;\"\u003e\n\n  \u003cdiv style=\"flex:1;min-width:150px;padding:12px 16px;background:#f6f6f7;border-radius:10px;\"\u003e\n\n    \u003cdiv style=\"font-size:.72em;text-transform:uppercase;letter-spacing:.08em;color:#9ca3af;margin-bottom:2px;\"\u003eCycle\u003c\/div\u003e\n\n    \u003cdiv style=\"font-weight:600;\"\u003eIntermittent nighttime use\u003c\/div\u003e\n\n  \u003c\/div\u003e\n\n  \u003cdiv style=\"flex:1;min-width:150px;padding:12px 16px;background:#f6f6f7;border-radius:10px;\"\u003e\n\n    \u003cdiv style=\"font-size:.72em;text-transform:uppercase;letter-spacing:.08em;color:#9ca3af;margin-bottom:2px;\"\u003eRest\u003c\/div\u003e\n\n    \u003cdiv style=\"font-weight:600;\"\u003eNot required\u003c\/div\u003e\n\n  \u003c\/div\u003e\n\n\n\u003c\/div\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eMechanism of action\u003c\/p\u003e\n\u003cp style=\"margin:1.1em 0 0.3em;font-weight:600;font-family:inherit;\"\u003eDeep sleep and circadian rhythm\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eIts name comes from its ability to promote delta wave sleep. It modulates glutamatergic signaling and GABAergic neurotransmission, key to the brain's excitation-inhibition balance.\u003c\/p\u003e\n\u003cp style=\"margin:1.1em 0 0.3em;font-weight:600;font-family:inherit;\"\u003eNeuroendocrine axis and stress\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eIt influences neuroendocrine pathways (CRF, ACTH, GnRH, LH, TSH, and GH axis) and monoaminergic systems (dopamine, serotonin, noradrenaline, histamine), with an anti-stress profile.\u003c\/p\u003e\n\u003cp style=\"margin:1.1em 0 0.3em;font-weight:600;font-family:inherit;\"\u003eAntioxidant defense and blood-brain barrier\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eIt increases the activity of antioxidant enzymes (GPx, SOD, catalase, glutathione reductase) and crosses the blood-brain barrier via transporters, facilitating its central action.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eScientific Evidence\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.7em;padding:10px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e\u003cstrong\u003eBrain distribution:\u003c\/strong\u003e Detected in the thalamus, cortex, cerebellum, hypothalamus, and brainstem, with fluctuations throughout the sleep-wake cycle.\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.7em;padding:10px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e\u003cstrong\u003eStress and hormones:\u003c\/strong\u003e Studies describe modulation of stress response and hormone release.\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.7em;padding:10px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e\u003cstrong\u003eAntioxidation:\u003c\/strong\u003e Cellular models confirm its antioxidant activity.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eProduct Use\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eDue to its direct link with delta sleep and its neuroendocrine profile, DSIP is a unique reference material in sleep, circadian rhythm, and stress research. At \u003cstrong\u003ePeptido BioGenetic\u003c\/strong\u003e, we offer it as a high-purity peptide for laboratory use, with a Certificate of Analysis (COA) available upon request.\u003c\/p\u003e\n\n\u003cp style=\"margin:1.6em 0 0;padding:12px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e⚠️ Product intended exclusively for \u003cstrong\u003eresearch and laboratory use\u003c\/strong\u003e. Not suitable for human or veterinary consumption.\u003c\/p\u003e","brand":"PeptidoBioGenetic","offers":[{"title":"10 mg","offer_id":54545811767625,"sku":"DS10","price":110.9,"currency_code":"EUR","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1016\/7507\/3865\/files\/dsip-5-mg-sin-fondo.png?v=1782819725"},{"product_id":"5-amino-1mq-50-mg","title":"5 AMINO 1MQ","description":"\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:0 0 .4em;font-family:inherit;\"\u003eWhat it is\u003c\/p\u003e\n\u003cp style=\"font-size:1.12em;line-height:1.7;margin:0 0 1em;\"\u003eIt is not a peptide; it is a \u003cstrong\u003esmall molecule that blocks an enzyme\u003c\/strong\u003e called NNMT. That enzyme is abundant in fat and in aged muscle, and inhibiting it changes how the cell manages its energy.\u003c\/p\u003e\n\u003cp style=\"font-size:1.02em;line-height:1.7;margin:0 0 1.2em;color:#374151;\"\u003eInside your cells there is a molecule called NAD⁺ that is, essentially, the currency used to pay for energy. An enzyme called NNMT keeps spending part of that currency. When there is too much NNMT —which happens in accumulated fat and in muscle with age— less NAD⁺ is available. 5-Amino-1MQ blocks that enzyme.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eWhat it is used for\u003c\/p\u003e\n\u003cul style=\"margin:0 0 1.2em;padding-left:0;list-style:none;line-height:1.9;\"\u003e\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Research on fat metabolism and adipocyte size\u003c\/li\u003e\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Intracellular NAD⁺ levels and cellular energy\u003c\/li\u003e\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Muscle function and age-related muscle loss\u003c\/li\u003e\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Studies on lipogenesis and cholesterol\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eHow it is used\u003c\/p\u003e\n\u003cdiv style=\"display:flex;gap:12px;margin:0 0 1.4em;flex-wrap:wrap;\"\u003e\n  \u003cdiv style=\"flex:1;min-width:150px;padding:12px 16px;background:#f6f6f7;border-radius:10px;\"\u003e\n    \u003cdiv style=\"font-size:.72em;text-transform:uppercase;letter-spacing:.08em;color:#9ca3af;margin-bottom:2px;\"\u003eCycle\u003c\/div\u003e\n    \u003cdiv style=\"font-weight:600;\"\u003e4–8 weeks\u003c\/div\u003e\n  \u003c\/div\u003e\n  \u003cdiv style=\"flex:1;min-width:150px;padding:12px 16px;background:#f6f6f7;border-radius:10px;\"\u003e\n    \u003cdiv style=\"font-size:.72em;text-transform:uppercase;letter-spacing:.08em;color:#9ca3af;margin-bottom:2px;\"\u003eBreak\u003c\/div\u003e\n    \u003cdiv style=\"font-weight:600;\"\u003e2–4 weeks\u003c\/div\u003e\n  \u003c\/div\u003e\n  \u003cdiv style=\"flex:1;min-width:150px;padding:12px 16px;background:#f6f6f7;border-radius:10px;\"\u003e\n    \u003cdiv style=\"font-size:.72em;text-transform:uppercase;letter-spacing:.08em;color:#9ca3af;margin-bottom:2px;\"\u003eRoute\u003c\/div\u003e\n    \u003cdiv style=\"font-weight:600;\"\u003eOral or subcutaneous\u003c\/div\u003e\n  \u003c\/div\u003e\n\u003c\/div\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eLyophilized powder. It is reconstituted with bacteriostatic water, swirled without shaking, and stored between 2 and 8 °C. Unlike most of the catalog, this molecule was specifically designed to cross membranes, which also allows the oral route \u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[1]\u003c\/sup\u003e.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eWhat has been observed\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;color:#6b7280;font-size:.95em;\"\u003eResults described in the published scientific literature. They are not directions for use or health recommendations.\u003c\/p\u003e\n\u003cul style=\"margin:0 0 1.2em;padding-left:0;list-style:none;line-height:1.9;\"\u003e\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  In mice with diet-induced obesity, a potent NNMT inhibitor significantly reduced body weight and white fat mass, decreased adipocyte size and lowered total plasma cholesterol \u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[1]\u003c\/sup\u003e\n\u003c\/li\u003e\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  That effect was achieved \u003cstrong\u003ewithout reducing food intake\u003c\/strong\u003e and without observable adverse effects, which points to a metabolic rather than an appetite mechanism \u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[1]\u003c\/sup\u003e\n\u003c\/li\u003e\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  In cultured adipocytes, NNMT inhibition increased intracellular NAD⁺ and suppressed lipogenesis \u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[1]\u003c\/sup\u003e\n\u003c\/li\u003e\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  In aged mice, NNMT inhibition mimicked and boosted the exercise-associated improvements in muscle function \u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[2]\u003c\/sup\u003e\n\u003c\/li\u003e\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  NNMT has been proposed as a therapeutic target in sarcopenia, the age-related loss of muscle mass and function \u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[3]\u003c\/sup\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eHow it works\u003c\/p\u003e\n\u003cp style=\"margin:1.1em 0 0.3em;font-weight:600;font-family:inherit;\"\u003eNicotinamide N-methyltransferase inhibition\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003e5-Amino-1MQ is a selective, membrane-permeable inhibitor of NNMT, the enzyme that methylates nicotinamide and converts it into 1-methylnicotinamide (1-MNA) \u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[1]\u003c\/sup\u003e. Blocking it lowers intracellular 1-MNA and raises NAD⁺ and S-adenosylmethionine.\u003c\/p\u003e\n\u003cp style=\"margin:1.1em 0 0.3em;font-weight:600;font-family:inherit;\"\u003eSelectivity\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eMethylquinolinium analogs with primary amine substitution showed high selectivity: they do not inhibit other SAM-dependent methyltransferases or the enzymes of the NAD⁺ salvage pathway \u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[1]\u003c\/sup\u003e. That selectivity is what makes the target viable.\u003c\/p\u003e\n\u003cp style=\"margin:1.1em 0 0.3em;font-weight:600;font-family:inherit;\"\u003eFrom adipose tissue to muscle\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eNNMT expression in adipocytes is regulated by glucose availability \u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[4]\u003c\/sup\u003e, and its inhibition has been explored in obesity as well as in aged muscle function and peripheral artery disease \u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[2]\u003c\/sup\u003e\u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[3]\u003c\/sup\u003e.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eState of the evidence\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.7em;padding:10px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e\u003cstrong\u003ePreclinical.\u003c\/strong\u003e The available data come from cell and mouse models published in pharmacology and aging biology journals \u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[1]\u003c\/sup\u003e\u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[2]\u003c\/sup\u003e\u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[3]\u003c\/sup\u003e. There are no human clinical trials with 5-Amino-1MQ: it is a target validated in preclinical research, not a proven treatment.\u003c\/p\u003e\n\n\u003cp style=\"margin:1.6em 0 0;padding:12px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e⚠️ Product intended exclusively for \u003cstrong\u003eresearch and laboratory use\u003c\/strong\u003e. Not for human or veterinary consumption.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eReferences\u003c\/p\u003e\n\u003col style=\"margin:0;padding-left:1.4em;font-size:.86em;color:#6b7280;line-height:1.7;\"\u003e\n  \u003cli\u003eNeelakantan H, et al. \u003cem\u003eSelective and membrane-permeable small molecule inhibitors of nicotinamide N-methyltransferase reverse high fat diet-induced obesity in mice.\u003c\/em\u003e Biochem Pharmacol, 2018. \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/29155147\/\" target=\"_blank\" rel=\"nofollow noopener\" style=\"color:#0099ff;text-decoration:none;\"\u003ePubMed 29155147\u003c\/a\u003e\n\u003c\/li\u003e\n  \u003cli\u003eDimet-Wiley AL, et al. \u003cem\u003eNicotinamide N-methyltransferase inhibition mimics and boosts exercise-mediated improvements in muscle function in aged mice.\u003c\/em\u003e Sci Rep, 2024. \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38969654\/\" target=\"_blank\" rel=\"nofollow noopener\" style=\"color:#0099ff;text-decoration:none;\"\u003ePubMed 38969654\u003c\/a\u003e\n\u003c\/li\u003e\n  \u003cli\u003eLiang R, et al. \u003cem\u003eIdentification of nicotinamide N-methyltransferase as a promising therapeutic target for sarcopenia.\u003c\/em\u003e Aging Cell, 2024. \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38838088\/\" target=\"_blank\" rel=\"nofollow noopener\" style=\"color:#0099ff;text-decoration:none;\"\u003ePubMed 38838088\u003c\/a\u003e\n\u003c\/li\u003e\n  \u003cli\u003eEhebauer F, et al. \u003cem\u003eGlucose availability regulates nicotinamide N-methyltransferase expression in adipocytes.\u003c\/em\u003e Life Sci, 2020. \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/32112869\/\" target=\"_blank\" rel=\"nofollow noopener\" style=\"color:#0099ff;text-decoration:none;\"\u003ePubMed 32112869\u003c\/a\u003e\n\u003c\/li\u003e\n\u003c\/ol\u003e","brand":"PeptidoBioGenetic","offers":[{"title":"10 mg","offer_id":54760592179529,"sku":"10AM","price":123.9,"currency_code":"EUR","in_stock":true},{"title":"50 mg","offer_id":54545849221449,"sku":"50AM","price":183.9,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1016\/7507\/3865\/files\/5-amino-1mq-50-mg-sin-fondo.png?v=1782819728"},{"product_id":"l-glutation-3000-mg","title":"L GLUTATHIONE","description":"\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:0 0 .4em;font-family:inherit;\"\u003eSummary\u003c\/p\u003e\n\u003cp style=\"font-size:1.05em;line-height:1.65;margin:0 0 1.2em;\"\u003e\u003cstrong\u003eL-Glutathione\u003c\/strong\u003e is studied as the cell's \u003cstrong\u003emaster antioxidant\u003c\/strong\u003e: it protects against oxidative stress, preserves redox balance, and participates in detoxification. Technically, it is the tripeptide GSH (γ-L-glutamyl-L-cysteinyl-glycine), formed by glutamate, cysteine, and glycine, and constitutes the primary antioxidant defense in virtually all tissues.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eWhat is it researched for?\u003c\/p\u003e\n\u003cul style=\"margin:0 0 1.2em;padding-left:0;list-style:none;line-height:1.9;\"\u003e\n\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Antioxidant defense and cellular redox balance\u003c\/li\u003e\n\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Mitochondrial and DNA protection\u003c\/li\u003e\n\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Phase II detoxification\u003c\/li\u003e\n\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Muscle recovery and fatigue reduction\u003c\/li\u003e\n\n\n\u003c\/ul\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eCycle and break\u003c\/p\u003e\n\u003cdiv style=\"display:flex;gap:12px;margin:0 0 1.4em;flex-wrap:wrap;\"\u003e\n\n  \u003cdiv style=\"flex:1;min-width:150px;padding:12px 16px;background:#f6f6f7;border-radius:10px;\"\u003e\n\n    \u003cdiv style=\"font-size:.72em;text-transform:uppercase;letter-spacing:.08em;color:#9ca3af;margin-bottom:2px;\"\u003eCycle\u003c\/div\u003e\n\n    \u003cdiv style=\"font-weight:600;\"\u003e4–8 weeks\u003c\/div\u003e\n\n  \u003c\/div\u003e\n\n  \u003cdiv style=\"flex:1;min-width:150px;padding:12px 16px;background:#f6f6f7;border-radius:10px;\"\u003e\n\n    \u003cdiv style=\"font-size:.72em;text-transform:uppercase;letter-spacing:.08em;color:#9ca3af;margin-bottom:2px;\"\u003eBreak\u003c\/div\u003e\n\n    \u003cdiv style=\"font-weight:600;\"\u003e2–4 weeks\u003c\/div\u003e\n\n  \u003c\/div\u003e\n\n\n\u003c\/div\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eMechanism of action\u003c\/p\u003e\n\u003cp style=\"margin:1.1em 0 0.3em;font-weight:600;font-family:inherit;\"\u003eCentral antioxidant defense\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eDirectly neutralizes reactive oxygen species (ROS) and maintains intracellular redox balance, protecting proteins, lipids, and DNA from oxidative damage.\u003c\/p\u003e\n\u003cp style=\"margin:1.1em 0 0.3em;font-weight:600;font-family:inherit;\"\u003eMitochondrial and DNA protection\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003ePreserves the integrity of mitochondrial membranes and participates in the repair of oxidative DNA damage.\u003c\/p\u003e\n\u003cp style=\"margin:1.1em 0 0.3em;font-weight:600;font-family:inherit;\"\u003eAntioxidant regeneration and detoxification\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eRecycles vitamins C and E to their active form and participates in phase II detoxification pathways.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eScientific evidence\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.7em;padding:10px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e\u003cstrong\u003eRedox balance:\u003c\/strong\u003e Its thiol (-SH) group is the most abundant reductant in the cell; its depletion is associated with cell damage in numerous models.\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.7em;padding:10px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e\u003cstrong\u003eCell survival:\u003c\/strong\u003e Oxidative stress models show greater cell survival in the presence of glutathione.\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.7em;padding:10px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e\u003cstrong\u003eMuscle recovery:\u003c\/strong\u003e Studied for its role in muscle recovery and fatigue reduction.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eProduct use\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eL-Glutathione is a key reference material in research on oxidative stress, cellular redox, and detoxification. At \u003cstrong\u003ePeptido BioGenetic\u003c\/strong\u003e, we offer it with high purity, with a certificate of analysis (COA) available upon request.\u003c\/p\u003e\n\n\u003cp style=\"margin:1.6em 0 0;padding:12px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e⚠️ Product intended exclusively for \u003cstrong\u003eresearch and laboratory use\u003c\/strong\u003e. Not suitable for human or veterinary consumption.\u003c\/p\u003e","brand":"PeptidoBioGenetic","offers":[{"title":"1500 mg","offer_id":54545849254217,"sku":"GT1500","price":160.9,"currency_code":"EUR","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1016\/7507\/3865\/files\/l-glutation-3000-mg-sin-fondo.png?v=1782819731"},{"product_id":"tirzepatida-20-mg","title":"TIRZEPATIDE","description":"\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:0 0 .4em;font-family:inherit;\"\u003eWhat it is\u003c\/p\u003e\n\u003cp style=\"font-size:1.12em;line-height:1.7;margin:0 0 1em;\"\u003eA peptide that mimics \u003cstrong\u003etwo appetite hormones at once\u003c\/strong\u003e instead of one. It is the intermediate step between the classic compounds, which copy only one hormone, and newer ones such as Retatrutide, which copy three.\u003c\/p\u003e\n\u003cp style=\"font-size:1.02em;line-height:1.7;margin:0 0 1.2em;color:#374151;\"\u003eWhen you eat, the gut releases hormones called incretins that signal the pancreas and the brain. Tirzepatide copies two of them: GLP-1, the best known, and GIP. By pressing both keys, the effect on appetite and blood sugar is greater than pressing only one.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eWhat it is used for\u003c\/p\u003e\n\u003cul style=\"margin:0 0 1.2em;padding-left:0;list-style:none;line-height:1.9;\"\u003e\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Research on weight and appetite control\u003c\/li\u003e\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Blood glucose control\u003c\/li\u003e\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Studies comparing it with compounds that copy only one hormone\u003c\/li\u003e\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Gastric emptying and satiety signals\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eHow it is used\u003c\/p\u003e\n\u003cdiv style=\"display:flex;gap:12px;margin:0 0 1.4em;flex-wrap:wrap;\"\u003e\n  \u003cdiv style=\"flex:1;min-width:150px;padding:12px 16px;background:#f6f6f7;border-radius:10px;\"\u003e\n    \u003cdiv style=\"font-size:.72em;text-transform:uppercase;letter-spacing:.08em;color:#9ca3af;margin-bottom:2px;\"\u003eCycle\u003c\/div\u003e\n    \u003cdiv style=\"font-weight:600;\"\u003eContinuous until target\u003c\/div\u003e\n  \u003c\/div\u003e\n  \u003cdiv style=\"flex:1;min-width:150px;padding:12px 16px;background:#f6f6f7;border-radius:10px;\"\u003e\n    \u003cdiv style=\"font-size:.72em;text-transform:uppercase;letter-spacing:.08em;color:#9ca3af;margin-bottom:2px;\"\u003eBreak\u003c\/div\u003e\n    \u003cdiv style=\"font-weight:600;\"\u003eNot required\u003c\/div\u003e\n  \u003c\/div\u003e\n  \u003cdiv style=\"flex:1;min-width:150px;padding:12px 16px;background:#f6f6f7;border-radius:10px;\"\u003e\n    \u003cdiv style=\"font-size:.72em;text-transform:uppercase;letter-spacing:.08em;color:#9ca3af;margin-bottom:2px;\"\u003eRoute\u003c\/div\u003e\n    \u003cdiv style=\"font-weight:600;\"\u003eWeekly subcutaneous\u003c\/div\u003e\n  \u003c\/div\u003e\n\u003c\/div\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eLyophilized powder. It is reconstituted with bacteriostatic water, swirled without shaking, and stored between 2 and 8 °C. In the literature it is administered once a week with gradual dose escalation, which is what makes the digestive effects tolerable \u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[1]\u003c\/sup\u003e.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eWhat has been observed\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;color:#6b7280;font-size:.95em;\"\u003eResults described in the published scientific literature. They are not directions for use or health recommendations.\u003c\/p\u003e\n\u003cul style=\"margin:0 0 1.2em;padding-left:0;list-style:none;line-height:1.9;\"\u003e\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  In SURPASS-1 (478 adults with type 2 diabetes, 40 weeks), weight loss was dose-dependent and ranged from \u003cstrong\u003e7.0 to 9.5 kg\u003c\/strong\u003e \u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[1]\u003c\/sup\u003e\n\u003c\/li\u003e\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  In the same trial, glycated hemoglobin fell by 1.87 to 2.07 points, versus an increase of 0.04 with placebo \u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[1]\u003c\/sup\u003e\n\u003c\/li\u003e\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Between 87% and 92% of participants reached an HbA1c below 7%, versus 20% with placebo \u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[1]\u003c\/sup\u003e\n\u003c\/li\u003e\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  The most frequent adverse effects were digestive, mild or moderate and transient: nausea (12-18% versus 6%), diarrhea and vomiting \u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[1]\u003c\/sup\u003e\n\u003c\/li\u003e\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  No severe or clinically significant hypoglycemia was reported with tirzepatide in that study \u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[1]\u003c\/sup\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eHow it works\u003c\/p\u003e\n\u003cp style=\"margin:1.1em 0 0.3em;font-weight:600;font-family:inherit;\"\u003eGIP \/ GLP-1 co-agonism\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eTirzepatide (LY-3298176) is a single peptide that simultaneously activates the GIP receptor and the GLP-1 receptor \u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[2]\u003c\/sup\u003e. The GLP-1 branch acts on the hypothalamic appetite centers, slows gastric emptying and enhances glucose-dependent insulin secretion.\u003c\/p\u003e\n\u003cp style=\"margin:1.1em 0 0.3em;font-weight:600;font-family:inherit;\"\u003eWhat the GIP branch contributes\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eThe role of GIP was debated for years. The hypothesis behind the design is that combined signaling improves insulin sensitivity in adipose tissue and enhances the effect of GLP-1 on intake beyond what GLP-1 achieves alone \u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[3]\u003c\/sup\u003e\u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[4]\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp style=\"margin:1.1em 0 0.3em;font-weight:600;font-family:inherit;\"\u003ePosition within its family\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eReviews describe it as the co-agonist with the best balance between glycemic control and weight reduction in its generation, and as the reference against which newer agonists are compared \u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[4]\u003c\/sup\u003e\u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[5]\u003c\/sup\u003e.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eState of the evidence\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.7em;padding:10px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e\u003cstrong\u003eClinical and extensive.\u003c\/strong\u003e A complete phase 3 program (SURPASS series) published in \u003cem\u003eThe Lancet\u003c\/em\u003e and reviewed in the endocrinology literature \u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[1]\u003c\/sup\u003e\u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[4]\u003c\/sup\u003e\u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[5]\u003c\/sup\u003e. As with the rest of the catalog, the material we offer is research grade: the clinical trials cited were conducted with a pharmaceutical product and under medical supervision.\u003c\/p\u003e\n\n\u003cp style=\"margin:1.6em 0 0;padding:12px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e⚠️ Product intended exclusively for \u003cstrong\u003eresearch and laboratory use\u003c\/strong\u003e. Not for human or veterinary consumption.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eReferences\u003c\/p\u003e\n\u003col style=\"margin:0;padding-left:1.4em;font-size:.86em;color:#6b7280;line-height:1.7;\"\u003e\n  \u003cli\u003eRosenstock J, et al. \u003cem\u003eEfficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial.\u003c\/em\u003e Lancet, 2021. \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34186022\/\" target=\"_blank\" rel=\"nofollow noopener\" style=\"color:#0099ff;text-decoration:none;\"\u003ePubMed 34186022\u003c\/a\u003e\n\u003c\/li\u003e\n  \u003cli\u003eCoskun T, et al. \u003cem\u003eLY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: from discovery to clinical proof of concept.\u003c\/em\u003e Mol Metab, 2018. \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/30473097\/\" target=\"_blank\" rel=\"nofollow noopener\" style=\"color:#0099ff;text-decoration:none;\"\u003ePubMed 30473097\u003c\/a\u003e\n\u003c\/li\u003e\n  \u003cli\u003eSamms RJ, et al. \u003cem\u003eHow May GIP Enhance the Therapeutic Efficacy of GLP-1?\u003c\/em\u003e Trends Endocrinol Metab, 2020. \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/32396843\/\" target=\"_blank\" rel=\"nofollow noopener\" style=\"color:#0099ff;text-decoration:none;\"\u003ePubMed 32396843\u003c\/a\u003e\n\u003c\/li\u003e\n  \u003cli\u003eNauck MA, et al. \u003cem\u003eTirzepatide, a dual GIP\/GLP-1 receptor co-agonist for the treatment of type 2 diabetes with unmatched effectiveness regarding glycaemic control and body weight reduction.\u003c\/em\u003e Cardiovasc Diabetol, 2022. \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/36050763\/\" target=\"_blank\" rel=\"nofollow noopener\" style=\"color:#0099ff;text-decoration:none;\"\u003ePubMed 36050763\u003c\/a\u003e\n\u003c\/li\u003e\n  \u003cli\u003eDrucker DJ, et al. \u003cem\u003eEfficacy and Safety of GLP-1 Medicines for Type 2 Diabetes and Obesity.\u003c\/em\u003e Diabetes Care, 2024. \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38843460\/\" target=\"_blank\" rel=\"nofollow noopener\" style=\"color:#0099ff;text-decoration:none;\"\u003ePubMed 38843460\u003c\/a\u003e\n\u003c\/li\u003e\n\u003c\/ol\u003e","brand":"PeptidoBioGenetic","offers":[{"title":"15 mg","offer_id":54603479777609,"sku":"TR15","price":192.9,"currency_code":"EUR","in_stock":false},{"title":"20 mg","offer_id":54545849286985,"sku":"TR20","price":239.9,"currency_code":"EUR","in_stock":true},{"title":"30 mg","offer_id":54603479810377,"sku":"TR30","price":278.9,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1016\/7507\/3865\/files\/tirzepatida-20-mg-sin-fondo.png?v=1782819734"},{"product_id":"nad-1000-mg","title":"NAD+","description":"\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:0 0 .4em;font-family:inherit;\"\u003eSummary\u003c\/p\u003e\n\u003cp style=\"font-size:1.05em;line-height:1.65;margin:0 0 1.2em;\"\u003e\u003cstrong\u003eNAD⁺\u003c\/strong\u003e is studied for its role in \u003cstrong\u003ecellular energy, DNA repair and molecular aging\u003c\/strong\u003e. Technically, it is the coenzyme nicotinamide adenine dinucleotide, present in every cell and central to energy production, redox reactions and cell signaling; its levels \u003cstrong\u003edecline with age\u003c\/strong\u003e, which has made it a key target in longevity research.\u003c\/p\u003e\n\n\u003cp data-pbg-nad style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eNAD⁺ is not the same as NAD\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003e“NAD” on its own is the name of the molecule, which exists in the body in two forms: \u003cstrong\u003eNAD⁺\u003c\/strong\u003e and \u003cstrong\u003eNADH\u003c\/strong\u003e. The “+” sign is not decoration: it marks the active form, the one the cell has free to work with.\u003c\/p\u003e\n\u003cdiv style=\"display:flex;gap:12px;margin:0 0 1.1em;flex-wrap:wrap;\"\u003e\n  \u003cdiv style=\"flex:1;min-width:150px;padding:12px 16px;background:#f6f6f7;border-radius:10px;text-align:left;\"\u003e\n\u003cdiv style=\"font-weight:600;\"\u003eNAD⁺ · the active form\u003c\/div\u003e\n\u003cdiv style=\"font-size:.92em;color:#4b5563;line-height:1.5;margin-top:3px;\"\u003eIt collects energy from nutrients and is the form consumed by the enzymes that repair DNA. It is also the form that declines with age.\u003c\/div\u003e\n\u003c\/div\u003e\n  \u003cdiv style=\"flex:1;min-width:150px;padding:12px 16px;background:#f6f6f7;border-radius:10px;text-align:left;\"\u003e\n\u003cdiv style=\"font-weight:600;\"\u003eNADH · the already-loaded form\u003c\/div\u003e\n\u003cdiv style=\"font-size:.92em;color:#4b5563;line-height:1.5;margin-top:3px;\"\u003eIt carries that energy to the mitochondria. It does not serve as raw material for cellular repair.\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eThis vial contains \u003cstrong\u003eNAD⁺ as is\u003c\/strong\u003e: not NADH, nor a precursor such as NMN or NR that the body would first have to convert. That is why it is the most researched form, mainly for three reasons: \u003cstrong\u003eenergy\u003c\/strong\u003e (it is essential for producing ATP), \u003cstrong\u003erepair\u003c\/strong\u003e (it fuels the enzymes that fix DNA) and \u003cstrong\u003eaging\u003c\/strong\u003e (its levels fall over the years).\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eWhat is it researched for?\u003c\/p\u003e\n\u003cul style=\"margin:0 0 1.2em;padding-left:0;list-style:none;line-height:1.9;\"\u003e\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Cellular energy production (ATP)\u003c\/li\u003e\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  DNA repair and sirtuin activity\u003c\/li\u003e\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Mitochondrial function and biogenesis\u003c\/li\u003e\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Molecular aging and longevity\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eCycle and break\u003c\/p\u003e\n\u003cdiv style=\"display:flex;gap:12px;margin:0 0 1.4em;flex-wrap:wrap;\"\u003e\n  \u003cdiv style=\"flex:1;min-width:150px;padding:12px 16px;background:#f6f6f7;border-radius:10px;\"\u003e\n    \u003cdiv style=\"font-size:.72em;text-transform:uppercase;letter-spacing:.08em;color:#9ca3af;margin-bottom:2px;\"\u003eCycle\u003c\/div\u003e\n    \u003cdiv style=\"font-weight:600;\"\u003e4–8 weeks\u003c\/div\u003e\n  \u003c\/div\u003e\n  \u003cdiv style=\"flex:1;min-width:150px;padding:12px 16px;background:#f6f6f7;border-radius:10px;\"\u003e\n    \u003cdiv style=\"font-size:.72em;text-transform:uppercase;letter-spacing:.08em;color:#9ca3af;margin-bottom:2px;\"\u003eBreak\u003c\/div\u003e\n    \u003cdiv style=\"font-weight:600;\"\u003e2–4 weeks\u003c\/div\u003e\n  \u003c\/div\u003e\n\u003c\/div\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eMechanism of action\u003c\/p\u003e\n\u003cp style=\"margin:1.1em 0 0.3em;font-weight:600;font-family:inherit;\"\u003eDriver of cellular energy\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eIt acts as a cofactor in glycolysis, the Krebs cycle and oxidative phosphorylation, transferring electrons in the oxidation-reduction reactions that generate ATP.\u003c\/p\u003e\n\u003cp style=\"margin:1.1em 0 0.3em;font-weight:600;font-family:inherit;\"\u003eDNA repair and sirtuins\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eIt is the substrate for sirtuins and PARP enzymes, which are involved in DNA repair, chromatin regulation and mitochondrial biogenesis.\u003c\/p\u003e\n\u003cp style=\"margin:1.1em 0 0.3em;font-weight:600;font-family:inherit;\"\u003eHomeostasis and signaling\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eIt regulates pathways of calcium homeostasis, inflammation and chromatin remodeling.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eScientific evidence\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.7em;padding:10px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e\u003cstrong\u003eCellular metabolism:\u003c\/strong\u003e It is one of the most widely used cofactors in cellular metabolism.\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.7em;padding:10px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e\u003cstrong\u003eAging:\u003c\/strong\u003e Its decline is associated with greater DNA damage, oxidative stress and mitochondrial dysfunction in aging models.\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.7em;padding:10px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e\u003cstrong\u003eNAD⁺ availability:\u003c\/strong\u003e Researched alongside modulators such as 5-Amino-1MQ for its role in NAD⁺ availability.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eProduct use\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eNAD⁺ is a core reference material in research on energy metabolism, mitochondria and longevity. At \u003cstrong\u003ePeptido BioGenetic\u003c\/strong\u003e we offer it in research grade, with a certificate of analysis (COA) available on request.\u003c\/p\u003e\n\n\u003cp style=\"margin:1.6em 0 0;padding:12px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e⚠️ Product intended exclusively for \u003cstrong\u003eresearch and laboratory use\u003c\/strong\u003e. Not for human or veterinary consumption.\u003c\/p\u003e","brand":"PeptidoBioGenetic","offers":[{"title":"500 mg","offer_id":55126422454601,"sku":"NJ500","price":178.9,"currency_code":"EUR","in_stock":true},{"title":"1000 mg","offer_id":54545849319753,"sku":"NJ1000","price":248.9,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1016\/7507\/3865\/files\/nad-1000-mg-sin-fondo.png?v=1782819737"},{"product_id":"bpc-157-tb-500-blend-20-mg","title":"BPC 157 + TB 500","description":"\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:0 0 .4em;font-family:inherit;\"\u003eWhat it is\u003c\/p\u003e\n\u003cp style=\"font-size:1.12em;line-height:1.7;margin:0 0 1em;\"\u003eTwo repair peptides in a single vial. They are studied for the same reason: \u003cstrong\u003ehelping the body repair damaged tissue\u003c\/strong\u003e —tendons, muscle, ligaments— faster than it would on its own.\u003c\/p\u003e\n\u003cp style=\"font-size:1.02em;line-height:1.7;margin:0 0 1.2em;color:#374151;\"\u003eBPC-157 is a laboratory copy of a small protein already present in human gastric juice. TB-500 is the active part of another protein, thymosin beta-4, which the body produces wherever there is a wound. Each one works in a different phase of repair, which is why they are combined.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eWhat it is used for\u003c\/p\u003e\n\u003cul style=\"margin:0 0 1.2em;padding-left:0;list-style:none;line-height:1.9;\"\u003e\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Tendon, ligament and muscle injuries that are slow to heal\u003c\/li\u003e\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Recovery after intense exertion or surgery\u003c\/li\u003e\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Digestive discomfort: the original research field of BPC-157\u003c\/li\u003e\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Laboratory work on wound healing and new blood vessel formation\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eHow it is used\u003c\/p\u003e\n\u003cdiv style=\"display:flex;gap:12px;margin:0 0 1.4em;flex-wrap:wrap;\"\u003e\n  \u003cdiv style=\"flex:1;min-width:150px;padding:12px 16px;background:#f6f6f7;border-radius:10px;\"\u003e\n    \u003cdiv style=\"font-size:.72em;text-transform:uppercase;letter-spacing:.08em;color:#9ca3af;margin-bottom:2px;\"\u003eCycle\u003c\/div\u003e\n    \u003cdiv style=\"font-weight:600;\"\u003e4–6 weeks\u003c\/div\u003e\n  \u003c\/div\u003e\n  \u003cdiv style=\"flex:1;min-width:150px;padding:12px 16px;background:#f6f6f7;border-radius:10px;\"\u003e\n    \u003cdiv style=\"font-size:.72em;text-transform:uppercase;letter-spacing:.08em;color:#9ca3af;margin-bottom:2px;\"\u003eBreak\u003c\/div\u003e\n    \u003cdiv style=\"font-weight:600;\"\u003e2–4 weeks\u003c\/div\u003e\n  \u003c\/div\u003e\n  \u003cdiv style=\"flex:1;min-width:150px;padding:12px 16px;background:#f6f6f7;border-radius:10px;\"\u003e\n    \u003cdiv style=\"font-size:.72em;text-transform:uppercase;letter-spacing:.08em;color:#9ca3af;margin-bottom:2px;\"\u003eRoute\u003c\/div\u003e\n    \u003cdiv style=\"font-weight:600;\"\u003eSubcutaneous\u003c\/div\u003e\n  \u003c\/div\u003e\n\u003c\/div\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eThe vial comes as a powder. It is reconstituted with bacteriostatic water, swirled gently until dissolved —never shaken— and kept in the refrigerator between 2 and 8 °C. Each vial contains 20 mg in total: 10 mg of each peptide.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eWhat has been observed\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;color:#6b7280;font-size:.95em;\"\u003eResults described in the published scientific literature. They are not directions for use or health recommendations.\u003c\/p\u003e\n\u003cul style=\"margin:0 0 1.2em;padding-left:0;list-style:none;line-height:1.9;\"\u003e\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Preclinical studies describe faster healing of tendon, muscle, bone and intestine with BPC-157, including reattachment of tendon to bone after Achilles tendon detachment \u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[2]\u003c\/sup\u003e\u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[3]\u003c\/sup\u003e\n\u003c\/li\u003e\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  BPC-157 has shown activity at very small doses and without demonstrable toxicity in the models reviewed \u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[2]\u003c\/sup\u003e\u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[5]\u003c\/sup\u003e\n\u003c\/li\u003e\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Thymosin beta-4 accelerates skin wound closure: in the original model, 42% more re-epithelialization at 4 days and up to 61% at 7 days \u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[7]\u003c\/sup\u003e\n\u003c\/li\u003e\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  It also reduces the number of myofibroblasts, which is associated with less scarring and less fibrosis \u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[9]\u003c\/sup\u003e\n\u003c\/li\u003e\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Thymosin beta-4 reached human studies for skin wounds, corneal injuries and cardiac repair \u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[9]\u003c\/sup\u003e\n\u003c\/li\u003e\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  The published pilot studies in people with BPC-157 reported no relevant adverse effects \u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[4]\u003c\/sup\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eHow it works\u003c\/p\u003e\n\u003cp style=\"margin:1.1em 0 0.3em;font-weight:600;font-family:inherit;\"\u003eBPC-157 — cytoprotection and angiogenesis\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eA stable pentadecapeptide derived from a gastric protein. In preclinical models it promotes angiogenesis, modulates the nitric oxide pathway and shows broad cytoprotective effects in gastrointestinal, musculoskeletal and nervous tissue \u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[2]\u003c\/sup\u003e. In tendon it promotes fibroblast outgrowth from the explant, their survival under stress and their migration, an effect attributed to activation of the FAK-paxillin pathway \u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[1]\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp style=\"margin:1.1em 0 0.3em;font-weight:600;font-family:inherit;\"\u003eTB-500 — cell migration and remodeling\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eThe active fraction of thymosin beta-4, the main actin-sequestering molecule in eukaryotic cells. It regulates the actin cytoskeleton and directs the migration of repair cells toward the injury, in addition to modulating the inflammatory response \u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[6]\u003c\/sup\u003e\u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[9]\u003c\/sup\u003e. Its own actin-binding site is responsible for promoting angiogenesis \u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[8]\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp style=\"margin:1.1em 0 0.3em;font-weight:600;font-family:inherit;\"\u003eWhy they are combined\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eThey cover complementary phases of the same cascade: BPC-157 provides cytoprotection, trophic signaling and blood vessel formation; TB-500 provides cell migration and cytoskeletal remodeling. Together they span more stages of the repair process than either one alone.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eState of the evidence\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.7em;padding:10px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e\u003cstrong\u003ePreclinical: solid; clinical: limited.\u003c\/strong\u003e Reviews published in 2025 note that in humans there are only pilot studies with BPC-157 —intra-articular knee pain, interstitial cystitis and an intravenous safety and pharmacokinetics study— and that large, rigorous clinical trials are lacking; the long-term safety profile has not been established \u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[4]\u003c\/sup\u003e\u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[5]\u003c\/sup\u003e. There are no published studies on the combined formulation: the available evidence is that of each component separately.\u003c\/p\u003e\n\n\u003cp style=\"margin:1.6em 0 0;padding:12px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e⚠️ Product intended exclusively for \u003cstrong\u003eresearch and laboratory use\u003c\/strong\u003e. Not for human or veterinary consumption.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eReferences\u003c\/p\u003e\n\u003col style=\"margin:0;padding-left:1.4em;font-size:.86em;color:#6b7280;line-height:1.7;\"\u003e\n  \u003cli\u003eChang CH, et al. \u003cem\u003eThe promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration.\u003c\/em\u003e J Appl Physiol, 2011. \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/21030672\/\" target=\"_blank\" rel=\"nofollow noopener\" style=\"color:#0099ff;text-decoration:none;\"\u003ePubMed 21030672\u003c\/a\u003e\n\u003c\/li\u003e\n  \u003cli\u003eGwyer D, et al. \u003cem\u003eGastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing.\u003c\/em\u003e Cell Tissue Res, 2019. \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/30915550\/\" target=\"_blank\" rel=\"nofollow noopener\" style=\"color:#0099ff;text-decoration:none;\"\u003ePubMed 30915550\u003c\/a\u003e\n\u003c\/li\u003e\n  \u003cli\u003eKrivic A, et al. \u003cem\u003eAchilles detachment in rat and stable gastric pentadecapeptide BPC 157: promoted tendon-to-bone healing and opposed corticosteroid aggravation.\u003c\/em\u003e J Orthop Res, 2006. \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/16583442\/\" target=\"_blank\" rel=\"nofollow noopener\" style=\"color:#0099ff;text-decoration:none;\"\u003ePubMed 16583442\u003c\/a\u003e\n\u003c\/li\u003e\n  \u003cli\u003eVasireddi N, et al. \u003cem\u003eEmerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review.\u003c\/em\u003e HSS J, 2025. \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40756949\/\" target=\"_blank\" rel=\"nofollow noopener\" style=\"color:#0099ff;text-decoration:none;\"\u003ePubMed 40756949\u003c\/a\u003e\n\u003c\/li\u003e\n  \u003cli\u003eMcGuire FP, et al. \u003cem\u003eRegeneration or Risk? A Narrative Review of BPC-157 for Musculoskeletal Healing.\u003c\/em\u003e Curr Rev Musculoskelet Med, 2025. \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40789979\/\" target=\"_blank\" rel=\"nofollow noopener\" style=\"color:#0099ff;text-decoration:none;\"\u003ePubMed 40789979\u003c\/a\u003e\n\u003c\/li\u003e\n  \u003cli\u003eGoldstein AL, et al. \u003cem\u003eThymosin beta4: actin-sequestering protein moonlights to repair injured tissues.\u003c\/em\u003e Trends Mol Med, 2005. \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/16099219\/\" target=\"_blank\" rel=\"nofollow noopener\" style=\"color:#0099ff;text-decoration:none;\"\u003ePubMed 16099219\u003c\/a\u003e\n\u003c\/li\u003e\n  \u003cli\u003eMalinda KM, et al. \u003cem\u003eThymosin beta4 accelerates wound healing.\u003c\/em\u003e J Invest Dermatol, 1999. \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/10469335\/\" target=\"_blank\" rel=\"nofollow noopener\" style=\"color:#0099ff;text-decoration:none;\"\u003ePubMed 10469335\u003c\/a\u003e\n\u003c\/li\u003e\n  \u003cli\u003ePhilp D, et al. \u003cem\u003eThe actin binding site on thymosin beta4 promotes angiogenesis.\u003c\/em\u003e FASEB J, 2003. \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/14500546\/\" target=\"_blank\" rel=\"nofollow noopener\" style=\"color:#0099ff;text-decoration:none;\"\u003ePubMed 14500546\u003c\/a\u003e\n\u003c\/li\u003e\n  \u003cli\u003eGoldstein AL, et al. \u003cem\u003eThymosin β4: a multi-functional regenerative peptide. Basic properties and clinical applications.\u003c\/em\u003e Expert Opin Biol Ther, 2012. \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/22074294\/\" target=\"_blank\" rel=\"nofollow noopener\" style=\"color:#0099ff;text-decoration:none;\"\u003ePubMed 22074294\u003c\/a\u003e\n\u003c\/li\u003e\n\u003c\/ol\u003e","brand":"PeptidoBioGenetic","offers":[{"title":"10 mg + 10 mg","offer_id":55126439788873,"sku":"BB10","price":140.9,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1016\/7507\/3865\/files\/bpc-157-tb-500-20-mg-sin-fondo.png?v=1787687072"},{"product_id":"selank-50-mg","title":"SELANK","description":"\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:0 0 .4em;font-family:inherit;\"\u003eSummary\u003c\/p\u003e\n\u003cp style=\"font-size:1.05em;line-height:1.65;margin:0 0 1.2em;\"\u003e\u003cstrong\u003eSelank\u003c\/strong\u003e is one of the most studied neuropeptides in the \u003cstrong\u003enootropic and anxiolytic\u003c\/strong\u003e fields: it is researched for its role in \u003cstrong\u003ereducing stress, improving mood, and enhancing mental focus without drowsiness\u003c\/strong\u003e. Technically, it is a synthetic heptapeptide (Thr-Lys-Pro-Arg-Pro-Gly-Pro) analogous to tuftsin, developed by the Russian Academy of Sciences, with an anxiolytic and nootropic profile without sedative effects.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eWhat is it researched for?\u003c\/p\u003e\n\u003cul style=\"margin:0 0 1.2em;padding-left:0;list-style:none;line-height:1.9;\"\u003e\n\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Stress and anxiety reduction without sedation\u003c\/li\u003e\n\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Mood and mental focus\u003c\/li\u003e\n\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Memory, learning, and synaptic plasticity\u003c\/li\u003e\n\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Neuroimmune communication\u003c\/li\u003e\n\n\n\u003c\/ul\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eCycle and break\u003c\/p\u003e\n\u003cdiv style=\"display:flex;gap:12px;margin:0 0 1.4em;flex-wrap:wrap;\"\u003e\n\n  \u003cdiv style=\"flex:1;min-width:150px;padding:12px 16px;background:#f6f6f7;border-radius:10px;\"\u003e\n\n    \u003cdiv style=\"font-size:.72em;text-transform:uppercase;letter-spacing:.08em;color:#9ca3af;margin-bottom:2px;\"\u003eCycle\u003c\/div\u003e\n\n    \u003cdiv style=\"font-weight:600;\"\u003e10–14 days\u003c\/div\u003e\n\n  \u003c\/div\u003e\n\n  \u003cdiv style=\"flex:1;min-width:150px;padding:12px 16px;background:#f6f6f7;border-radius:10px;\"\u003e\n\n    \u003cdiv style=\"font-size:.72em;text-transform:uppercase;letter-spacing:.08em;color:#9ca3af;margin-bottom:2px;\"\u003eBreak\u003c\/div\u003e\n\n    \u003cdiv style=\"font-weight:600;\"\u003e1–2 weeks\u003c\/div\u003e\n\n  \u003c\/div\u003e\n\n\n\u003c\/div\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eMechanism of action\u003c\/p\u003e\n\u003cp style=\"margin:1.1em 0 0.3em;font-weight:600;font-family:inherit;\"\u003eGABAergic and anxiolytic modulation\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eIt acts as a positive allosteric modulator of GABA-A receptors, which is the basis of its anxiolytic effect, and regulates dopaminergic and serotonergic neurotransmission.\u003c\/p\u003e\n\u003cp style=\"margin:1.1em 0 0.3em;font-weight:600;font-family:inherit;\"\u003eNeurotrophism and plasticity\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eIt increases BDNF in the hippocampus and promotes neurogenesis and synaptic plasticity, which are linked to memory and cognition.\u003c\/p\u003e\n\u003cp style=\"margin:1.1em 0 0.3em;font-weight:600;font-family:inherit;\"\u003eNeuroimmune modulation\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eIt regulates the production of IL-6 and interferons, connecting the stress response with the immune system.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eScientific evidence\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.7em;padding:10px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e\u003cstrong\u003eAnxiolysis:\u003c\/strong\u003e Anxiety models describe anxiolytic effect without sedation or dependence.\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.7em;padding:10px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e\u003cstrong\u003eBDNF and learning:\u003c\/strong\u003e Studies in rodents document increased BDNF and improved learning.\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.7em;padding:10px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e\u003cstrong\u003eNeuroimmunity:\u003c\/strong\u003e Researched in the regulation of stress response and neuroimmune communication.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eProduct use\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eDue to its anxiolytic effect without sedation and its action on BDNF, Selank is a prominent reference material in neurocognitive and stress research. At \u003cstrong\u003ePeptido BioGenetic\u003c\/strong\u003e, we offer it as a high-purity peptide for laboratory use, with a Certificate of Analysis (COA) available upon request.\u003c\/p\u003e\n\n\u003cp style=\"margin:1.6em 0 0;padding:12px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e⚠️ Product intended exclusively for \u003cstrong\u003eresearch and laboratory use\u003c\/strong\u003e. Not suitable for human or veterinary consumption.\u003c\/p\u003e","brand":"PeptidoBioGenetic","offers":[{"title":"10 mg","offer_id":54545849450825,"sku":"SK10","price":82.9,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1016\/7507\/3865\/files\/selank-50-mg-sin-fondo.png?v=1782819741"},{"product_id":"mots-c-20-mg","title":"MOTS C","description":"\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:0 0 .4em;font-family:inherit;\"\u003eSummary\u003c\/p\u003e\n\u003cp style=\"font-size:1.05em;line-height:1.65;margin:0 0 1.2em;\"\u003e\u003cstrong\u003eMOTS-c\u003c\/strong\u003e is studied as a \u003cstrong\u003emetabolic regulator\u003c\/strong\u003e: it improves physical endurance, insulin sensitivity, and the conversion of fat to energy. Technically, it is a 16-amino acid mitochondrial peptide, encoded by mitochondrial DNA itself and discovered in 2015, which is considered an \u003cstrong\u003e\"exercise mimetic\"\u003c\/strong\u003e due to its ability to improve metabolic efficiency.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eWhat is it researched for?\u003c\/p\u003e\n\u003cul style=\"margin:0 0 1.2em;padding-left:0;list-style:none;line-height:1.9;\"\u003e\n\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Metabolic efficiency and physical endurance\u003c\/li\u003e\n\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Insulin sensitivity and glucose metabolism\u003c\/li\u003e\n\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Conversion of fat to energy\u003c\/li\u003e\n\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Metabolic aging and neuroprotection\u003c\/li\u003e\n\n\n\u003c\/ul\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eCycle and break\u003c\/p\u003e\n\u003cdiv style=\"display:flex;gap:12px;margin:0 0 1.4em;flex-wrap:wrap;\"\u003e\n\n  \u003cdiv style=\"flex:1;min-width:150px;padding:12px 16px;background:#f6f6f7;border-radius:10px;\"\u003e\n\n    \u003cdiv style=\"font-size:.72em;text-transform:uppercase;letter-spacing:.08em;color:#9ca3af;margin-bottom:2px;\"\u003eCycle\u003c\/div\u003e\n\n    \u003cdiv style=\"font-weight:600;\"\u003e4–6 weeks\u003c\/div\u003e\n\n  \u003c\/div\u003e\n\n  \u003cdiv style=\"flex:1;min-width:150px;padding:12px 16px;background:#f6f6f7;border-radius:10px;\"\u003e\n\n    \u003cdiv style=\"font-size:.72em;text-transform:uppercase;letter-spacing:.08em;color:#9ca3af;margin-bottom:2px;\"\u003eBreak\u003c\/div\u003e\n\n    \u003cdiv style=\"font-weight:600;\"\u003e4 weeks\u003c\/div\u003e\n\n  \u003c\/div\u003e\n\n\n\u003c\/div\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eMechanism of action\u003c\/p\u003e\n\u003cp style=\"margin:1.1em 0 0.3em;font-weight:600;font-family:inherit;\"\u003eAMPK activation and metabolism\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eIt activates the AMPK pathway, the cell's master energy sensor, and regulates purine and glucose metabolism, promoting mitochondrial efficiency.\u003c\/p\u003e\n\u003cp style=\"margin:1.1em 0 0.3em;font-weight:600;font-family:inherit;\"\u003eMitochondria-nucleus communication\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eIt is one of the few peptides that translocates from the mitochondria to the nucleus to directly modulate gene expression in response to metabolic stress.\u003c\/p\u003e\n\u003cp style=\"margin:1.1em 0 0.3em;font-weight:600;font-family:inherit;\"\u003eAging and neuroprotection\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eIt is being investigated in metabolic disorders, age-related conditions, and neurodegenerative diseases.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eScientific evidence\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.7em;padding:10px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e\u003cstrong\u003eMetabolism:\u003c\/strong\u003e Studies describe improved insulin sensitivity and glucose metabolism, replicating exercise effects.\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.7em;padding:10px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e\u003cstrong\u003eNuclear translocation:\u003c\/strong\u003e Its nuclear translocation under cellular stress has been documented since its discovery (Lee et al., 2015).\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.7em;padding:10px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e\u003cstrong\u003eLongevity and neuroprotection:\u003c\/strong\u003e Preclinical models support effects on metabolic longevity and neuroprotection.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eProduct use\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eAs a mitochondria-derived peptide with exercise mimetic action, MOTS-c is a unique reference material in metabolism and aging research. At \u003cstrong\u003ePeptido BioGenetic\u003c\/strong\u003e, we offer it as a high-purity peptide, with a certificate of analysis (COA) available upon request.\u003c\/p\u003e\n\n\u003cp style=\"margin:1.6em 0 0;padding:12px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e⚠️ Product intended exclusively for \u003cstrong\u003eresearch and laboratory use\u003c\/strong\u003e. Not suitable for human or veterinary consumption.\u003c\/p\u003e","brand":"PeptidoBioGenetic","offers":[{"title":"10 mg","offer_id":55126422421833,"sku":"MS10","price":103.9,"currency_code":"EUR","in_stock":true},{"title":"40 mg","offer_id":54545849483593,"sku":"MS40","price":178.9,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1016\/7507\/3865\/files\/mots-c-20-mg-sin-fondo.png?v=1782819744"},{"product_id":"tesamorelina-10-mg","title":"TESAMORELIN","description":"\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:0 0 .4em;font-family:inherit;\"\u003eSummary\u003c\/p\u003e\n\u003cp style=\"font-size:1.05em;line-height:1.65;margin:0 0 1.2em;\"\u003e\u003cstrong\u003eTesamorelin\u003c\/strong\u003e is one of the most robust research peptides in the \u003cstrong\u003egrowth hormone\u003c\/strong\u003e axis: it is studied for its role in \u003cstrong\u003evisceral fat, metabolism, and body composition\u003c\/strong\u003e. Technically, it is a synthetic analog of 44-amino acid GHRH, stabilized with a trans-3-hexenoyl group, and is one of the GHRH analogs with the most clinical support, with regulatory approval for the reduction of visceral fat.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eWhat is it being researched for?\u003c\/p\u003e\n\u003cul style=\"margin:0 0 1.2em;padding-left:0;list-style:none;line-height:1.9;\"\u003e\n\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Reduction of visceral fat\u003c\/li\u003e\n\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Physiological stimulation of growth hormone\u003c\/li\u003e\n\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Body composition and muscle density\u003c\/li\u003e\n\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Lipid profile and metabolic markers\u003c\/li\u003e\n\n\n\u003c\/ul\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eCycle and Rest\u003c\/p\u003e\n\u003cdiv style=\"display:flex;gap:12px;margin:0 0 1.4em;flex-wrap:wrap;\"\u003e\n\n  \u003cdiv style=\"flex:1;min-width:150px;padding:12px 16px;background:#f6f6f7;border-radius:10px;\"\u003e\n\n    \u003cdiv style=\"font-size:.72em;text-transform:uppercase;letter-spacing:.08em;color:#9ca3af;margin-bottom:2px;\"\u003eCycle\u003c\/div\u003e\n\n    \u003cdiv style=\"font-weight:600;\"\u003e3–6 months (5 days\/week)\u003c\/div\u003e\n\n  \u003c\/div\u003e\n\n  \u003cdiv style=\"flex:1;min-width:150px;padding:12px 16px;background:#f6f6f7;border-radius:10px;\"\u003e\n\n    \u003cdiv style=\"font-size:.72em;text-transform:uppercase;letter-spacing:.08em;color:#9ca3af;margin-bottom:2px;\"\u003eRest\u003c\/div\u003e\n\n    \u003cdiv style=\"font-weight:600;\"\u003e1 month\u003c\/div\u003e\n\n  \u003c\/div\u003e\n\n\n\u003c\/div\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eMechanism of action\u003c\/p\u003e\n\u003cp style=\"margin:1.1em 0 0.3em;font-weight:600;font-family:inherit;\"\u003ePhysiological stimulation of growth hormone\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eIt acts on the GHRH receptor, preserving the pulsatile release of growth hormone and the hepatic production of IGF-1, without altering its natural pattern.\u003c\/p\u003e\n\u003cp style=\"margin:1.1em 0 0.3em;font-weight:600;font-family:inherit;\"\u003eReduction of visceral fat\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eIts most studied application is the reduction of visceral adipose tissue, with improvement in lipid profile and metabolic markers.\u003c\/p\u003e\n\u003cp style=\"margin:1.1em 0 0.3em;font-weight:600;font-family:inherit;\"\u003eMetabolism and body composition\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eIts effect on mitochondrial biogenesis, fatty acid β-oxidation, and the AMPK and PI3K\/AKT\/mTOR pathways is being investigated.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eScientific evidence\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.7em;padding:10px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e\u003cstrong\u003eStability:\u003c\/strong\u003e its chemical modification gives it greater stability than native GHRH, prolonging its action.\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.7em;padding:10px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e\u003cstrong\u003eVisceral fat:\u003c\/strong\u003e clinical trials describe significant reductions in visceral fat; it is the only GHRH analog with approval for this indication (HIV-associated lipodystrophy).\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.7em;padding:10px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e\u003cstrong\u003eBody composition:\u003c\/strong\u003e clinical programs support improvements in body composition and metabolic function.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eProduct Use\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eWith clinical approval for visceral fat reduction, Tesamorelin is a top-tier reference material in research on the somatotropic axis and metabolism. At \u003cstrong\u003ePeptido BioGenetic\u003c\/strong\u003e, we offer it as a high-purity peptide for laboratory use, with a certificate of analysis (COA) available upon request.\u003c\/p\u003e\n\n\u003cp style=\"margin:1.6em 0 0;padding:12px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e⚠️ Product exclusively for \u003cstrong\u003eresearch and laboratory use\u003c\/strong\u003e. Not suitable for human or veterinary consumption.\u003c\/p\u003e","brand":"PeptidoBioGenetic","offers":[{"title":"15 mg","offer_id":54545849549129,"sku":"TSM10","price":162.9,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1016\/7507\/3865\/files\/tesamorelina-10-mg-sin-fondo.png?v=1782819752"},{"product_id":"ss-31-20-mg","title":"SS 31","description":"\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:0 0 .4em;font-family:inherit;\"\u003eSummary\u003c\/p\u003e\n\u003cp style=\"font-size:1.05em;line-height:1.65;margin:0 0 1.2em;\"\u003e\u003cstrong\u003eSS-31\u003c\/strong\u003e is one of the benchmark peptides in \u003cstrong\u003emitochondrial and bioenergetic\u003c\/strong\u003e research: it is studied for its role in protecting mitochondria and cellular energy production. Technically, it is a mitochondrion-targeting tetrapeptide (elamipretide) that selectively binds to cardiolipin in the inner mitochondrial membrane.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eWhy is it being researched?\u003c\/p\u003e\n\u003cul style=\"margin:0 0 1.2em;padding-left:0;list-style:none;line-height:1.9;\"\u003e\n\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Mitochondrial function and bioenergetics\u003c\/li\u003e\n\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  ATP synthesis and membrane potential\u003c\/li\u003e\n\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Oxidative stress and reactive oxygen species\u003c\/li\u003e\n\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Age-related mitochondrial decline and frailty\u003c\/li\u003e\n\n\n\u003c\/ul\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eCycle and break\u003c\/p\u003e\n\u003cdiv style=\"display:flex;gap:12px;margin:0 0 1.4em;flex-wrap:wrap;\"\u003e\n\n  \u003cdiv style=\"flex:1;min-width:150px;padding:12px 16px;background:#f6f6f7;border-radius:10px;\"\u003e\n\n    \u003cdiv style=\"font-size:.72em;text-transform:uppercase;letter-spacing:.08em;color:#9ca3af;margin-bottom:2px;\"\u003eCycle\u003c\/div\u003e\n\n    \u003cdiv style=\"font-weight:600;\"\u003e4–8 weeks\u003c\/div\u003e\n\n  \u003c\/div\u003e\n\n  \u003cdiv style=\"flex:1;min-width:150px;padding:12px 16px;background:#f6f6f7;border-radius:10px;\"\u003e\n\n    \u003cdiv style=\"font-size:.72em;text-transform:uppercase;letter-spacing:.08em;color:#9ca3af;margin-bottom:2px;\"\u003eBreak\u003c\/div\u003e\n\n    \u003cdiv style=\"font-weight:600;\"\u003e2–4 weeks\u003c\/div\u003e\n\n  \u003c\/div\u003e\n\n\n\u003c\/div\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eMechanism of action\u003c\/p\u003e\n\u003cp style=\"margin:1.1em 0 0.3em;font-weight:600;font-family:inherit;\"\u003eMitochondrial membrane protection\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eIt stabilizes cardiolipin and cristae morphology, preserves membrane potential, and enhances ATP synthesis via oxidative phosphorylation, reducing reactive oxygen species.\u003c\/p\u003e\n\u003cp style=\"margin:1.1em 0 0.3em;font-weight:600;font-family:inherit;\"\u003eAging and mitochondrial dysfunction\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eIt is being investigated in age-related mitochondrial decline and frailty.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eScientific evidence\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.7em;padding:10px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e\u003cstrong\u003eBioenergetics:\u003c\/strong\u003e cardiovascular damage and neuroprotection models support its improvement of cellular bioenergetics.\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.7em;padding:10px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e\u003cstrong\u003eClinical development:\u003c\/strong\u003e Elamipretide received FDA approval (2025) for Barth syndrome, a mitochondrial disease.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eProduct use\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eSS-31 is a premier reference material in mitochondrial bioenergetics research. At \u003cstrong\u003ePeptido BioGenetic\u003c\/strong\u003e, we offer it as a high-purity peptide for laboratory use, with a Certificate of Analysis (COA) available upon request.\u003c\/p\u003e\n\n\u003cp style=\"margin:1.6em 0 0;padding:12px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e⚠️ Product intended exclusively for \u003cstrong\u003eresearch and laboratory use\u003c\/strong\u003e. Not suitable for human or veterinary consumption.\u003c\/p\u003e","brand":"PeptidoBioGenetic","offers":[{"title":"10 mg","offer_id":54545904763209,"sku":"2S10","price":70.9,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1016\/7507\/3865\/files\/ss-31-20-mg-sin-fondo.png?v=1787668477"},{"product_id":"igf-1-lr3-1-mg","title":"IGF-1 LR3","description":"\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:0 0 .4em;font-family:inherit;\"\u003eSummary\u003c\/p\u003e\n\u003cp style=\"font-size:1.05em;line-height:1.65;margin:0 0 1.2em;\"\u003e\u003cstrong\u003eIGF-1 LR3\u003c\/strong\u003e (Long R3 IGF-1) is the long-acting variant of insulin-like growth factor 1, studied for its role in \u003cstrong\u003emuscle hyperplasia, recovery, and nutrient transport\u003c\/strong\u003e. Technically, it is an 83-amino acid analog with an arginine substitution at position 3 and a 13-residue peptide extension at the N-terminal end, which drastically reduces its binding to transport proteins (IGFBPs), prolonging its half-life and biological activity compared to native IGF-1.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eWhat is it researched for?\u003c\/p\u003e\n\u003cul style=\"margin:0 0 1.2em;padding-left:0;list-style:none;line-height:1.9;\"\u003e\n\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Hyperplasia and muscle tissue growth\u003c\/li\u003e\n\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Anabolic signaling via IGF-1R\u003c\/li\u003e\n\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Transport of amino acids and glucose into cells\u003c\/li\u003e\n\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Muscle tissue recovery\u003c\/li\u003e\n\n\n\u003c\/ul\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eCycle and rest\u003c\/p\u003e\n\u003cdiv style=\"display:flex;gap:12px;margin:0 0 1.4em;flex-wrap:wrap;\"\u003e\n\n  \u003cdiv style=\"flex:1;min-width:150px;padding:12px 16px;background:#f6f6f7;border-radius:10px;\"\u003e\n\n    \u003cdiv style=\"font-size:.72em;text-transform:uppercase;letter-spacing:.08em;color:#9ca3af;margin-bottom:2px;\"\u003eCycle\u003c\/div\u003e\n\n    \u003cdiv style=\"font-weight:600;\"\u003e4 weeks (max.)\u003c\/div\u003e\n\n  \u003c\/div\u003e\n\n  \u003cdiv style=\"flex:1;min-width:150px;padding:12px 16px;background:#f6f6f7;border-radius:10px;\"\u003e\n\n    \u003cdiv style=\"font-size:.72em;text-transform:uppercase;letter-spacing:.08em;color:#9ca3af;margin-bottom:2px;\"\u003eRest\u003c\/div\u003e\n\n    \u003cdiv style=\"font-weight:600;\"\u003e4–6 weeks\u003c\/div\u003e\n\n  \u003c\/div\u003e\n\n\n\u003c\/div\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eMechanism of action\u003c\/p\u003e\n\u003cp style=\"margin:1.1em 0 0.3em;font-weight:600;font-family:inherit;\"\u003eIGF-1R Receptor Agonism\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eIt activates the IGF-1 receptor (IGF-1R) and triggers the PI3K\/Akt\/mTOR and MAPK\/ERK pathways, central routes for protein synthesis, proliferation, and cell survival.\u003c\/p\u003e\n\u003cp style=\"margin:1.1em 0 0.3em;font-weight:600;font-family:inherit;\"\u003eProlonged half-life due to low affinity for IGFBP\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eThe N-terminal extension and the Arg3 substitution reduce its capture by circulating IGFBPs, so a larger fraction remains free and active, multiplying its potency compared to recombinant IGF-1.\u003c\/p\u003e\n\u003cp style=\"margin:1.1em 0 0.3em;font-weight:600;font-family:inherit;\"\u003eHyperplasia and nutrient uptake\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eIt is investigated for its role in hyperplasia (proliferation of new cells), the transport of amino acids and glucose into cells, and muscle tissue recovery.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eScientific evidence\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.7em;padding:10px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e\u003cstrong\u003eIGF-1R Signaling:\u003c\/strong\u003e receptor studies describe potent anabolic signaling through the PI3K\/Akt pathway, which is the basis of its effect on cell growth.\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.7em;padding:10px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e\u003cstrong\u003eBiological Potency:\u003c\/strong\u003e in vitro models, Long R3 IGF-1 shows several times higher biological potency than native IGF-1 due to its reduced sequestration by IGFBP.\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.7em;padding:10px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e\u003cstrong\u003eMuscle Tissue:\u003c\/strong\u003e preclinical data associate IGF-1 signaling with myoblast proliferation and muscle tissue growth.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eProduct use\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eDue to its prolonged half-life and potent signaling through IGF-1R, IGF-1 LR3 is a prominent reference material in growth factor, hypertrophy, and cellular hyperplasia research. At \u003cstrong\u003ePeptido BioGenetic\u003c\/strong\u003e, we supply it as a high-purity peptide for laboratory use, with a Certificate of Analysis (COA) available upon request.\u003c\/p\u003e\n\n\u003cp style=\"margin:1.6em 0 0;padding:12px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e⚠️ Product intended exclusively for \u003cstrong\u003eresearch and laboratory use\u003c\/strong\u003e. Not suitable for human or veterinary consumption.\u003c\/p\u003e","brand":"PeptidoBioGenetic","offers":[{"title":"1 mg","offer_id":54548710293833,"sku":"IGF1","price":145.9,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1016\/7507\/3865\/files\/igf-1-lr3-1-mg-sin-fondo.png?v=1782819765"},{"product_id":"kisspeptin-10-5-mg","title":"KISSPEPTIN 10","description":"\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:0 0 .4em;font-family:inherit;\"\u003eSummary\u003c\/p\u003e\n\u003cp style=\"font-size:1.05em;line-height:1.65;margin:0 0 1.2em;\"\u003e\u003cstrong\u003eKisspeptin-10\u003c\/strong\u003e is one of the reference peptides in the \u003cstrong\u003eendocrine and reproductive\u003c\/strong\u003e field: it is being researched for its role in the \u003cstrong\u003enatural production of sex hormones and the balance of the reproductive axis\u003c\/strong\u003e. Technically, it is the 10-amino acid C-terminal fragment of kisspeptin (product of the KISS1 gene, also called metastin), an agonist of the KISS1R receptor (GPR54) and one of the master regulators located upstream of GnRH in the hypothalamic-pituitary-gonadal axis.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eWhat is it researched for?\u003c\/p\u003e\n\u003cul style=\"margin:0 0 1.2em;padding-left:0;list-style:none;line-height:1.9;\"\u003e\n\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Regulation of the reproductive and endocrine axis\u003c\/li\u003e\n\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Secretion of gonadotropins (LH and FSH)\u003c\/li\u003e\n\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Fertility, puberty, and gonadal function\u003c\/li\u003e\n\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Interaction between metabolic status and reproduction\u003c\/li\u003e\n\n\n\u003c\/ul\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eCycle and break\u003c\/p\u003e\n\u003cdiv style=\"display:flex;gap:12px;margin:0 0 1.4em;flex-wrap:wrap;\"\u003e\n\n  \u003cdiv style=\"flex:1;min-width:150px;padding:12px 16px;background:#f6f6f7;border-radius:10px;\"\u003e\n\n    \u003cdiv style=\"font-size:.72em;text-transform:uppercase;letter-spacing:.08em;color:#9ca3af;margin-bottom:2px;\"\u003eCycle\u003c\/div\u003e\n\n    \u003cdiv style=\"font-weight:600;\"\u003e4–6 weeks\u003c\/div\u003e\n\n  \u003c\/div\u003e\n\n  \u003cdiv style=\"flex:1;min-width:150px;padding:12px 16px;background:#f6f6f7;border-radius:10px;\"\u003e\n\n    \u003cdiv style=\"font-size:.72em;text-transform:uppercase;letter-spacing:.08em;color:#9ca3af;margin-bottom:2px;\"\u003eBreak\u003c\/div\u003e\n\n    \u003cdiv style=\"font-weight:600;\"\u003e2–4 weeks\u003c\/div\u003e\n\n  \u003c\/div\u003e\n\n\n\u003c\/div\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eMechanism of action\u003c\/p\u003e\n\u003cp style=\"margin:1.1em 0 0.3em;font-weight:600;font-family:inherit;\"\u003eRegulation of the reproductive axis (GnRH stimulation)\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eStimulates hypothalamic GnRH neurons, triggering the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) from the pituitary, the initial step in the reproductive cascade.\u003c\/p\u003e\n\u003cp style=\"margin:1.1em 0 0.3em;font-weight:600;font-family:inherit;\"\u003eSignaling via KISS1R receptor (GPR54)\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eBinds to the G protein-coupled receptor KISS1R (GPR54), activating the Gq\/11-phospholipase C pathway, with mobilization of intracellular calcium and activation of the MAPK cascade.\u003c\/p\u003e\n\u003cp style=\"margin:1.1em 0 0.3em;font-weight:600;font-family:inherit;\"\u003eResearch in reproduction and metabolism\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eIt is being researched in the context of fertility, puberty, gonadal function, and the interaction between metabolic status and reproduction.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eScientific evidence\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.7em;padding:10px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e\u003cstrong\u003eLH secretion:\u003c\/strong\u003e In human studies, kisspeptin administration robustly induces LH secretion (Dhillo et al.), confirming its role as an activator of the gonadotropic axis.\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.7em;padding:10px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e\u003cstrong\u003eGPR54 receptor:\u003c\/strong\u003e Loss of GPR54 function is associated with hypogonadotropic hypogonadism, establishing kisspeptin as an essential regulator of puberty and fertility.\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.7em;padding:10px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e\u003cstrong\u003eClinical application:\u003c\/strong\u003e Clinical programs are exploring kisspeptin as a tool to physiologically modulate gonadotropin secretion.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eProduct use\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eAs a master regulator located upstream of GnRH, Kisspeptin-10 is a unique reference material in reproductive endocrinology research and the hypothalamic-pituitary-gonadal axis. At \u003cstrong\u003ePeptido BioGenetic\u003c\/strong\u003e, we supply it as a high-purity peptide for laboratory use, with a certificate of analysis (COA) available upon request.\u003c\/p\u003e\n\n\u003cp style=\"margin:1.6em 0 0;padding:12px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e⚠️ Product intended exclusively for \u003cstrong\u003eresearch and laboratory use\u003c\/strong\u003e. Not suitable for human or veterinary consumption.\u003c\/p\u003e","brand":"PeptidoBioGenetic","offers":[{"title":"10 mg","offer_id":54548710326601,"sku":"KS10","price":132.9,"currency_code":"EUR","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1016\/7507\/3865\/files\/kisspeptin-10-5-mg-sin-fondo.png?v=1782819768"},{"product_id":"pt-141","title":"PT 141","description":"\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:0 0 .4em;font-family:inherit;\"\u003eSummary\u003c\/p\u003e\n\u003cp style=\"font-size:1.05em;line-height:1.65;margin:0 0 1.2em;\"\u003e\u003cstrong\u003ePT-141\u003c\/strong\u003e is one of the reference peptides in the field of \u003cstrong\u003esexual function and neuroendocrinology\u003c\/strong\u003e: it is being researched for its role in \u003cstrong\u003esexual desire and response through the central nervous system\u003c\/strong\u003e. Technically, it is a cyclic 7-amino acid peptide, an analog of α-MSH, which acts as an agonist of melanocortin receptors (mainly MC4R and MC1R) and, unlike vascular modulators, exerts its action at the central level.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eWhat is it researched for?\u003c\/p\u003e\n\u003cul style=\"margin:0 0 1.2em;padding-left:0;list-style:none;line-height:1.9;\"\u003e\n\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Central-origin sexual desire and response\u003c\/li\u003e\n\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Female and male sexual function\u003c\/li\u003e\n\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Biology of the melanocortin system\u003c\/li\u003e\n\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Hypothalamic MC4R receptor signaling\u003c\/li\u003e\n\n\n\u003c\/ul\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eCycle and rest\u003c\/p\u003e\n\u003cdiv style=\"display:flex;gap:12px;margin:0 0 1.4em;flex-wrap:wrap;\"\u003e\n\n  \u003cdiv style=\"flex:1;min-width:150px;padding:12px 16px;background:#f6f6f7;border-radius:10px;\"\u003e\n\n    \u003cdiv style=\"font-size:.72em;text-transform:uppercase;letter-spacing:.08em;color:#9ca3af;margin-bottom:2px;\"\u003eCycle\u003c\/div\u003e\n\n    \u003cdiv style=\"font-weight:600;\"\u003ePunctual use\u003c\/div\u003e\n\n  \u003c\/div\u003e\n\n  \u003cdiv style=\"flex:1;min-width:150px;padding:12px 16px;background:#f6f6f7;border-radius:10px;\"\u003e\n\n    \u003cdiv style=\"font-size:.72em;text-transform:uppercase;letter-spacing:.08em;color:#9ca3af;margin-bottom:2px;\"\u003eRest\u003c\/div\u003e\n\n    \u003cdiv style=\"font-weight:600;\"\u003eNot applicable\u003c\/div\u003e\n\n  \u003c\/div\u003e\n\n\n\u003c\/div\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eMechanism of action\u003c\/p\u003e\n\u003cp style=\"margin:1.1em 0 0.3em;font-weight:600;font-family:inherit;\"\u003eMelanocortin receptor agonism (MC4R\/MC1R)\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eIt activates melanocortin receptors in the central nervous system, especially hypothalamic MC4R, a pathway involved in regulating sexual desire independent of the vascular route.\u003c\/p\u003e\n\u003cp style=\"margin:1.1em 0 0.3em;font-weight:600;font-family:inherit;\"\u003eCentral, not vascular, pathway\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eIts mechanism differs from that of PDE5 inhibitors: instead of acting on blood flow, it modulates brain signals associated with arousal.\u003c\/p\u003e\n\u003cp style=\"margin:1.1em 0 0.3em;font-weight:600;font-family:inherit;\"\u003eResearch in sexual function\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eIt is being researched in both female and male sexual dysfunction, as well as in the biology of the melanocortin system.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eScientific evidence\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.7em;padding:10px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e\u003cstrong\u003eCentral mechanism:\u003c\/strong\u003e PT-141 was approved by the FDA in 2019 (Vyleesi) for hypoactive sexual desire in premenopausal women, which supports its central mechanism of action.\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.7em;padding:10px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e\u003cstrong\u003ePhase 3 trials:\u003c\/strong\u003e Phase 3 clinical trials (RECONNECT program) documented an increase in sexual desire compared to placebo.\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.7em;padding:10px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e\u003cstrong\u003eSexual function:\u003c\/strong\u003e Clinical programs have evaluated its effect on sexual response in both sexes.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eProduct use\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eDue to its central mechanism via the melanocortin system, PT-141 is a unique reference material for research into sexual function and neuroendocrinology. At \u003cstrong\u003ePeptido BioGenetic\u003c\/strong\u003e, we supply it as a high-purity peptide for laboratory use, with a certificate of analysis (COA) available upon request.\u003c\/p\u003e\n\n\u003cp style=\"margin:1.6em 0 0;padding:12px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e⚠️ Product intended exclusively for \u003cstrong\u003eresearch and laboratory use\u003c\/strong\u003e. Not suitable for human or veterinary consumption.\u003c\/p\u003e","brand":"PeptidoBioGenetic","offers":[{"title":"10 mg","offer_id":54603569135945,"sku":"PT41","price":85.9,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1016\/7507\/3865\/files\/pt-141-sin-fondo.png?v=1782819771"},{"product_id":"melanotan-ii","title":"MELANOTAN II","description":"\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:0 0 .4em;font-family:inherit;\"\u003eSummary\u003c\/p\u003e\n\u003cp style=\"font-size:1.05em;line-height:1.65;margin:0 0 1.2em;\"\u003e\u003cstrong\u003eMelanotan II\u003c\/strong\u003e is one of the most studied peptides in the field of \u003cstrong\u003epigmentation and the melanocortin system\u003c\/strong\u003e: it is researched for its role in \u003cstrong\u003emelanogenesis (melanin production) and melanocortin receptor biology\u003c\/strong\u003e. Technically, it is a cyclic synthetic α-MSH analog and a non-selective agonist of melanocortin receptors (MC1R, MC3R, MC4R, and MC5R).\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eWhat is it researched for?\u003c\/p\u003e\n\u003cul style=\"margin:0 0 1.2em;padding-left:0;list-style:none;line-height:1.9;\"\u003e\n\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Melanogenesis and skin pigmentation\u003c\/li\u003e\n\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  UV radiation-independent photoprotection\u003c\/li\u003e\n\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Melanocortin receptor biology\u003c\/li\u003e\n\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Central signaling via MC4R\u003c\/li\u003e\n\n\n\u003c\/ul\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eCycle and rest\u003c\/p\u003e\n\u003cdiv style=\"display:flex;gap:12px;margin:0 0 1.4em;flex-wrap:wrap;\"\u003e\n\n  \u003cdiv style=\"flex:1;min-width:150px;padding:12px 16px;background:#f6f6f7;border-radius:10px;\"\u003e\n\n    \u003cdiv style=\"font-size:.72em;text-transform:uppercase;letter-spacing:.08em;color:#9ca3af;margin-bottom:2px;\"\u003eCycle\u003c\/div\u003e\n\n    \u003cdiv style=\"font-weight:600;\"\u003eLoading phase + maintenance\u003c\/div\u003e\n\n  \u003c\/div\u003e\n\n  \u003cdiv style=\"flex:1;min-width:150px;padding:12px 16px;background:#f6f6f7;border-radius:10px;\"\u003e\n\n    \u003cdiv style=\"font-size:.72em;text-transform:uppercase;letter-spacing:.08em;color:#9ca3af;margin-bottom:2px;\"\u003eRest\u003c\/div\u003e\n\n    \u003cdiv style=\"font-weight:600;\"\u003eVariable\u003c\/div\u003e\n\n  \u003c\/div\u003e\n\n\n\u003c\/div\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eMechanism of action\u003c\/p\u003e\n\u003cp style=\"margin:1.1em 0 0.3em;font-weight:600;font-family:inherit;\"\u003eMelanogenesis via MC1R\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eActivation of the MC1R receptor in melanocytes stimulates eumelanin synthesis, which is the basis for its study in skin pigmentation and photoprotection.\u003c\/p\u003e\n\u003cp style=\"margin:1.1em 0 0.3em;font-weight:600;font-family:inherit;\"\u003eMelanocortin system (MC4R)\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eAs a non-selective agonist, it also acts on MC4R, a pathway involved in appetite regulation and sexual function.\u003c\/p\u003e\n\u003cp style=\"margin:1.1em 0 0.3em;font-weight:600;font-family:inherit;\"\u003eResearch in pigmentation\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eIt is researched in the context of pigmentation, photoprotection, and the biology of various melanocortin receptors.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eScientific evidence\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.7em;padding:10px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e\u003cstrong\u003eMelanogenesis:\u003c\/strong\u003e Studies describe an increase in MC1R-mediated melanogenesis, independent of UV radiation exposure.\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.7em;padding:10px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e\u003cstrong\u003eMelanocortin system:\u003c\/strong\u003e Preclinical models document effects on the central melanocortin system.\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.7em;padding:10px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e\u003cstrong\u003eReceptor affinity:\u003c\/strong\u003e Literature describes its affinity for multiple melanocortin receptor subtypes.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eProduct use\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eDue to its action on melanogenesis and the melanocortin system, Melanotan II is a prominent reference material in research on pigmentation and melanocortin receptors. At \u003cstrong\u003ePeptido BioGenetic\u003c\/strong\u003e, we supply it as a high-purity peptide for laboratory use, with a Certificate of Analysis (COA) available upon request.\u003c\/p\u003e\n\n\u003cp style=\"margin:1.6em 0 0;padding:12px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e⚠️ Product intended exclusively for \u003cstrong\u003eresearch and laboratory use\u003c\/strong\u003e. Not for human or veterinary consumption.\u003c\/p\u003e","brand":"PeptidoBioGenetic","offers":[{"title":"10 mg","offer_id":54603569168713,"sku":"MT2","price":81.9,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1016\/7507\/3865\/files\/melanotan-ii-sin-fondo.png?v=1782819774"},{"product_id":"cjc-1295-ipamorelin-20-mg","title":"CJC 1295 + IPAMORELIN","description":"\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:0 0 .4em;font-family:inherit;\"\u003eSummary\u003c\/p\u003e\n\u003cp style=\"font-size:1.05em;line-height:1.65;margin:0 0 1.2em;\"\u003eThe \u003cstrong\u003eCJC-1295 without DAC + Ipamorelin\u003c\/strong\u003e blend is researched for its role in the \u003cstrong\u003epulsatile release of the body's own growth hormone\u003c\/strong\u003e. It combines in a single vial a GHRH analog and a selective ghrelin receptor agonist: two different pathways that converge on the pituitary gland.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eWhat is it researched for?\u003c\/p\u003e\n\u003cul style=\"margin:0 0 1.2em;padding-left:0;list-style:none;line-height:1.9;\"\u003e\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Pulsatile secretion of endogenous GH\u003c\/li\u003e\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  GH \/ IGF-1 axis\u003c\/li\u003e\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Body composition and recovery\u003c\/li\u003e\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Deep sleep quality\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eCycle and break\u003c\/p\u003e\n\u003cdiv style=\"display:flex;gap:12px;margin:0 0 1.4em;flex-wrap:wrap;\"\u003e\n  \u003cdiv style=\"flex:1;min-width:150px;padding:12px 16px;background:#f6f6f7;border-radius:10px;\"\u003e\n    \u003cdiv style=\"font-size:.72em;text-transform:uppercase;letter-spacing:.08em;color:#9ca3af;margin-bottom:2px;\"\u003eCycle\u003c\/div\u003e\n    \u003cdiv style=\"font-weight:600;\"\u003e8–12 weeks\u003c\/div\u003e\n  \u003c\/div\u003e\n  \u003cdiv style=\"flex:1;min-width:150px;padding:12px 16px;background:#f6f6f7;border-radius:10px;\"\u003e\n    \u003cdiv style=\"font-size:.72em;text-transform:uppercase;letter-spacing:.08em;color:#9ca3af;margin-bottom:2px;\"\u003eBreak\u003c\/div\u003e\n    \u003cdiv style=\"font-weight:600;\"\u003e4 weeks\u003c\/div\u003e\n  \u003c\/div\u003e\n\u003c\/div\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eMechanism of action\u003c\/p\u003e\n\u003cp style=\"margin:1.1em 0 0.3em;font-weight:600;font-family:inherit;\"\u003eCJC-1295 without DAC — GHRH analog\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eA modified version of the GRF(1-29) fragment that binds to the pituitary GHRH receptor and amplifies the amplitude of the GH pulse. Without DAC technology its half-life is short, so it respects the natural pulsatile pattern.\u003c\/p\u003e\n\u003cp style=\"margin:1.1em 0 0.3em;font-weight:600;font-family:inherit;\"\u003eIpamorelin — selective ghrelin agonist\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eA pentapeptide that activates the GHS-R1a receptor. Its distinguishing feature is selectivity: unlike classic GHRPs, it barely raises cortisol or prolactin.\u003c\/p\u003e\n\u003cp style=\"margin:1.1em 0 0.3em;font-weight:600;font-family:inherit;\"\u003eSynergy at the pituitary\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eEach component acts on a different receptor. When combined, an additive effect on the GH pulse is studied that is greater than that of either one alone.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eScientific evidence\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.7em;padding:10px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e\u003cstrong\u003eCJC-1295:\u003c\/strong\u003e Studies with the GRF(1-29) fragment document dose-dependent increases in GH and IGF-1 in healthy subjects.\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.7em;padding:10px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e\u003cstrong\u003eIpamorelin:\u003c\/strong\u003e Described in the literature as the most selective secretagogue in its family, with a clean endocrine profile.\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.7em;padding:10px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e\u003cstrong\u003eSynergy:\u003c\/strong\u003e The GHRH + GHRP combination is a classic in research on the somatotropic axis. An honest note: there are no controlled human studies of this specific combined formulation.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eProduct use\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eThis blend brings together the two complementary secretagogue mechanisms in a single reference material for in vitro and laboratory research. At \u003cstrong\u003ePeptido BioGenetic\u003c\/strong\u003e we offer it with high-purity components and a certificate of analysis (COA) available on request.\u003c\/p\u003e\n\n\u003cp style=\"margin:1.6em 0 0;padding:12px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e⚠️ Product intended exclusively for \u003cstrong\u003eresearch and laboratory use\u003c\/strong\u003e. Not for human or veterinary consumption.\u003c\/p\u003e","brand":"Peptido Biogenetic","offers":[{"title":"20 mg","offer_id":55005233905993,"sku":"CP20","price":230.9,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1016\/7507\/3865\/files\/cjc-1295-ipamorelin-20-mg-sin-fondo.png?v=1787687081"},{"product_id":"cagrilintide-semaglutide-10-mg","title":"CAGRILINTIDE + SEMAGLUTIDE","description":"\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:0 0 .4em;font-family:inherit;\"\u003eWhat it is\u003c\/p\u003e\n\u003cp style=\"font-size:1.12em;line-height:1.7;margin:0 0 1em;\"\u003eThe \u003cstrong\u003ebody's two satiety pathways, in a single vial\u003c\/strong\u003e. It combines the amylin analog with the most studied GLP-1 analog in the world. In the literature it is known as CagriSema.\u003c\/p\u003e\n\u003cp style=\"font-size:1.02em;line-height:1.7;margin:0 0 1.2em;color:#374151;\"\u003eThe body has two different systems for saying “enough”: incretins, which come from the gut, and amylin, which comes from the pancreas. Each one works on its own. This combination activates both at once, which is why the combined effect is greater than that of either one separately.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eWhat it is used for\u003c\/p\u003e\n\u003cul style=\"margin:0 0 1.2em;padding-left:0;list-style:none;line-height:1.9;\"\u003e\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Research on weight control through two simultaneous pathways\u003c\/li\u003e\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Satiety, appetite and gastric emptying\u003c\/li\u003e\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Studies of the combination versus each component separately\u003c\/li\u003e\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Body composition and cardiometabolic risk factors\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eHow it is used\u003c\/p\u003e\n\u003cdiv style=\"display:flex;gap:12px;margin:0 0 1.4em;flex-wrap:wrap;\"\u003e\n  \u003cdiv style=\"flex:1;min-width:150px;padding:12px 16px;background:#f6f6f7;border-radius:10px;\"\u003e\n    \u003cdiv style=\"font-size:.72em;text-transform:uppercase;letter-spacing:.08em;color:#9ca3af;margin-bottom:2px;\"\u003eCycle\u003c\/div\u003e\n    \u003cdiv style=\"font-weight:600;\"\u003eContinuous until target\u003c\/div\u003e\n  \u003c\/div\u003e\n  \u003cdiv style=\"flex:1;min-width:150px;padding:12px 16px;background:#f6f6f7;border-radius:10px;\"\u003e\n    \u003cdiv style=\"font-size:.72em;text-transform:uppercase;letter-spacing:.08em;color:#9ca3af;margin-bottom:2px;\"\u003eBreak\u003c\/div\u003e\n    \u003cdiv style=\"font-weight:600;\"\u003eNot required\u003c\/div\u003e\n  \u003c\/div\u003e\n  \u003cdiv style=\"flex:1;min-width:150px;padding:12px 16px;background:#f6f6f7;border-radius:10px;\"\u003e\n    \u003cdiv style=\"font-size:.72em;text-transform:uppercase;letter-spacing:.08em;color:#9ca3af;margin-bottom:2px;\"\u003eRoute\u003c\/div\u003e\n    \u003cdiv style=\"font-weight:600;\"\u003eWeekly subcutaneous\u003c\/div\u003e\n  \u003c\/div\u003e\n\u003c\/div\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eLyophilized powder with both peptides already combined. It is reconstituted with bacteriostatic water, swirled without shaking, and stored between 2 and 8 °C. In clinical trials it is administered once a week with gradual escalation \u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[1]\u003c\/sup\u003e.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eWhat has been observed\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;color:#6b7280;font-size:.95em;\"\u003eResults described in the published scientific literature. They are not directions for use or health recommendations.\u003c\/p\u003e\n\u003cul style=\"margin:0 0 1.2em;padding-left:0;list-style:none;line-height:1.9;\"\u003e\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  In the phase 3 REDEFINE 1 trial (3,417 adults, 68 weeks), the mean weight reduction was \u003cstrong\u003e20.4%\u003c\/strong\u003e versus 3.0% with placebo \u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[1]\u003c\/sup\u003e\n\u003c\/li\u003e\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Participants reached weight loss targets of 5%, 20%, 25% and even 30% of body weight far more often \u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[1]\u003c\/sup\u003e\n\u003c\/li\u003e\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  For reference, semaglutide alone reached 14.9% at 68 weeks in STEP 1, and cagrilintide alone 10.8% in its phase 2 \u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[4]\u003c\/sup\u003e\u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[5]\u003c\/sup\u003e\n\u003c\/li\u003e\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Digestive effects were frequent (79.6% versus 39.9% with placebo), but mostly transient and mild to moderate in intensity \u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[1]\u003c\/sup\u003e\n\u003c\/li\u003e\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  An analysis of REDEFINE 1 also described a reduction in blood pressure \u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[7]\u003c\/sup\u003e\n\u003c\/li\u003e\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  There are also phase 3 data in people with type 2 diabetes \u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[2]\u003c\/sup\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eHow it works\u003c\/p\u003e\n\u003cp style=\"margin:1.1em 0 0.3em;font-weight:600;font-family:inherit;\"\u003eSemaglutide — GLP-1 receptor agonist\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eAn analog of the incretin GLP-1 with substitutions that extend its half-life enough to allow weekly administration. It acts on the hypothalamic appetite centers and on glucose-dependent insulin secretion \u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[4]\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp style=\"margin:1.1em 0 0.3em;font-weight:600;font-family:inherit;\"\u003eCagrilintide — amylin analog\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eA long-acting amylin analog designed to resist degradation \u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[6]\u003c\/sup\u003e. It acts on amylin and calcitonin receptors in the area postrema and slows gastric emptying \u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[5]\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp style=\"margin:1.1em 0 0.3em;font-weight:600;font-family:inherit;\"\u003eWhy they add up\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eIncretins and amylin are independent signaling systems that converge on the same behavior: stopping eating. The phase 1b trial already described an additive effect, and phase 3 confirmed it versus each component separately \u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[3]\u003c\/sup\u003e\u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[1]\u003c\/sup\u003e.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eState of the evidence\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.7em;padding:10px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e\u003cstrong\u003eBest in its category.\u003c\/strong\u003e Phase 3 published in \u003cem\u003eThe New England Journal of Medicine\u003c\/em\u003e with more than three thousand participants, additional data in type 2 diabetes and secondary analyses on blood pressure \u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[1]\u003c\/sup\u003e\u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[2]\u003c\/sup\u003e\u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[7]\u003c\/sup\u003e. Even so, the combination is not approved as a medicine, and the material we offer is research grade, not pharmaceutical grade.\u003c\/p\u003e\n\n\u003cp style=\"margin:1.6em 0 0;padding:12px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e⚠️ Product intended exclusively for \u003cstrong\u003eresearch and laboratory use\u003c\/strong\u003e. Not for human or veterinary consumption.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eReferences\u003c\/p\u003e\n\u003col style=\"margin:0;padding-left:1.4em;font-size:.86em;color:#6b7280;line-height:1.7;\"\u003e\n  \u003cli\u003eGarvey WT, et al. \u003cem\u003eCoadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity.\u003c\/em\u003e N Engl J Med, 2025. \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40544433\/\" target=\"_blank\" rel=\"nofollow noopener\" style=\"color:#0099ff;text-decoration:none;\"\u003ePubMed 40544433\u003c\/a\u003e\n\u003c\/li\u003e\n  \u003cli\u003eDavies MJ, et al. \u003cem\u003eCagrilintide-Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes.\u003c\/em\u003e N Engl J Med, 2025. \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40544432\/\" target=\"_blank\" rel=\"nofollow noopener\" style=\"color:#0099ff;text-decoration:none;\"\u003ePubMed 40544432\u003c\/a\u003e\n\u003c\/li\u003e\n  \u003cli\u003eEnebo LB, et al. \u003cem\u003eSafety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2.4 mg for weight management: a randomised, controlled, phase 1b trial.\u003c\/em\u003e Lancet, 2021. \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/33894838\/\" target=\"_blank\" rel=\"nofollow noopener\" style=\"color:#0099ff;text-decoration:none;\"\u003ePubMed 33894838\u003c\/a\u003e\n\u003c\/li\u003e\n  \u003cli\u003eWilding JPH, et al. \u003cem\u003eOnce-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1).\u003c\/em\u003e N Engl J Med, 2021. \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/33567185\/\" target=\"_blank\" rel=\"nofollow noopener\" style=\"color:#0099ff;text-decoration:none;\"\u003ePubMed 33567185\u003c\/a\u003e\n\u003c\/li\u003e\n  \u003cli\u003eLau DCW, et al. \u003cem\u003eOnce-weekly cagrilintide for weight management in people with overweight and obesity: a phase 2 dose-finding trial.\u003c\/em\u003e Lancet, 2021. \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34798060\/\" target=\"_blank\" rel=\"nofollow noopener\" style=\"color:#0099ff;text-decoration:none;\"\u003ePubMed 34798060\u003c\/a\u003e\n\u003c\/li\u003e\n  \u003cli\u003eKruse T, et al. \u003cem\u003eDevelopment of Cagrilintide, a Long-Acting Amylin Analogue.\u003c\/em\u003e J Med Chem, 2021. \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34288673\/\" target=\"_blank\" rel=\"nofollow noopener\" style=\"color:#0099ff;text-decoration:none;\"\u003ePubMed 34288673\u003c\/a\u003e\n\u003c\/li\u003e\n  \u003cli\u003eVerma S, et al. \u003cem\u003eCagriSema Reduces Blood Pressure in Adults With Overweight or Obesity: REDEFINE 1.\u003c\/em\u003e Hypertension, 2026. \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/41328546\/\" target=\"_blank\" rel=\"nofollow noopener\" style=\"color:#0099ff;text-decoration:none;\"\u003ePubMed 41328546\u003c\/a\u003e\n\u003c\/li\u003e\n\u003c\/ol\u003e","brand":"Peptido Biogenetic","offers":[{"title":"10 mg","offer_id":55005234037065,"sku":"CS10","price":242.9,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1016\/7507\/3865\/files\/cagrilintide-semaglutide-10-mg-sin-fondo.png?v=1787687090"},{"product_id":"hgh-191aa-36-iu","title":"HGH 191AA","description":"\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:0 0 .4em;font-family:inherit;\"\u003eSummary\u003c\/p\u003e\n\u003cp style=\"font-size:1.05em;line-height:1.65;margin:0 0 1.2em;\"\u003e\u003cstrong\u003eHGH 191AA\u003c\/strong\u003e is somatropin: \u003cstrong\u003efull-sequence recombinant human growth hormone\u003c\/strong\u003e, with its 191 amino acids identical to those of the endogenous molecule. Unlike secretagogues, it supplies the hormone directly instead of stimulating the pituitary to release it.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eWhat is it researched for?\u003c\/p\u003e\n\u003cul style=\"margin:0 0 1.2em;padding-left:0;list-style:none;line-height:1.9;\"\u003e\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  GH \/ IGF-1 axis and somatotropic signaling\u003c\/li\u003e\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Body composition and protein turnover\u003c\/li\u003e\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Lipid and glucose metabolism\u003c\/li\u003e\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Tissue recovery and repair\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eCycle and break\u003c\/p\u003e\n\u003cdiv style=\"display:flex;gap:12px;margin:0 0 1.4em;flex-wrap:wrap;\"\u003e\n  \u003cdiv style=\"flex:1;min-width:150px;padding:12px 16px;background:#f6f6f7;border-radius:10px;\"\u003e\n    \u003cdiv style=\"font-size:.72em;text-transform:uppercase;letter-spacing:.08em;color:#9ca3af;margin-bottom:2px;\"\u003eCycle\u003c\/div\u003e\n    \u003cdiv style=\"font-weight:600;\"\u003e12–24 weeks\u003c\/div\u003e\n  \u003c\/div\u003e\n  \u003cdiv style=\"flex:1;min-width:150px;padding:12px 16px;background:#f6f6f7;border-radius:10px;\"\u003e\n    \u003cdiv style=\"font-size:.72em;text-transform:uppercase;letter-spacing:.08em;color:#9ca3af;margin-bottom:2px;\"\u003eBreak\u003c\/div\u003e\n    \u003cdiv style=\"font-weight:600;\"\u003e6–8 weeks\u003c\/div\u003e\n  \u003c\/div\u003e\n\u003c\/div\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eMechanism of action\u003c\/p\u003e\n\u003cp style=\"margin:1.1em 0 0.3em;font-weight:600;font-family:inherit;\"\u003eSomatropin — complete 191AA sequence\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eProduced by recombinant DNA technology, it reproduces the 191-amino-acid chain of human GH. The 191AA designation distinguishes it from 192-amino-acid variants, which carry an extra methionine.\u003c\/p\u003e\n\u003cp style=\"margin:1.1em 0 0.3em;font-weight:600;font-family:inherit;\"\u003eGH receptor pathway\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eIt binds to the GH receptor and activates the JAK2\/STAT5 cascade, which induces hepatic production of IGF-1, the main mediator of its peripheral effects.\u003c\/p\u003e\n\u003cp style=\"margin:1.1em 0 0.3em;font-weight:600;font-family:inherit;\"\u003eMeasured in international units\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eIt is quantified in IU rather than milligrams, the standard convention for protein hormones. For reference, 1 mg is approximately equivalent to 3 IU.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eScientific evidence\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.7em;padding:10px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e\u003cstrong\u003eWell-characterized molecule:\u003c\/strong\u003e Recombinant somatropin is one of the best-described therapeutic proteins in modern pharmacology, in clinical use since the 1980s.\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.7em;padding:10px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e\u003cstrong\u003eGH \/ IGF-1 axis:\u003c\/strong\u003e The literature documents in detail the dose-response relationship between exogenous GH and circulating IGF-1 levels.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eProduct use\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eTop-tier reference material for in vitro and laboratory research on the somatotropic axis. At \u003cstrong\u003ePeptido BioGenetic\u003c\/strong\u003e we offer it with high-purity components and a certificate of analysis (COA) available on request.\u003c\/p\u003e\n\n\u003cp style=\"margin:1.6em 0 0;padding:12px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e⚠️ Product intended exclusively for \u003cstrong\u003eresearch and laboratory use\u003c\/strong\u003e. Not for human or veterinary consumption.\u003c\/p\u003e","brand":"Peptido Biogenetic","offers":[{"title":"36 IU","offer_id":55005234069833,"sku":"H36","price":242.9,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1016\/7507\/3865\/files\/hgh-191aa-36-iu-sin-fondo.png?v=1787687101"},{"product_id":"retatrutide-cagrilintide","title":"Retatrutide + Cagrilintide","description":"\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:0 0 .4em;font-family:inherit;\"\u003eWhat it is\u003c\/p\u003e\n\u003cp style=\"font-size:1.12em;line-height:1.7;margin:0 0 1em;\"\u003eThe most ambitious combination in the catalog: the compound that copies \u003cstrong\u003ethree hormones at once\u003c\/strong\u003e —the most potent published— together with the amylin analog. Four different satiety and energy expenditure signals in a single vial.\u003c\/p\u003e\n\u003cp style=\"font-size:1.02em;line-height:1.7;margin:0 0 1.2em;color:#374151;\"\u003eRetatrutide already presses three keys: two that curb hunger and one that increases energy burn. Cagrilintide adds a fourth, amylin, which is independent of the others and prolongs the feeling of fullness. The idea is to cover energy balance from both sides at once: what comes in and what is spent.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eWhat it is used for\u003c\/p\u003e\n\u003cul style=\"margin:0 0 1.2em;padding-left:0;list-style:none;line-height:1.9;\"\u003e\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Research on weight control combining incretins and amylin\u003c\/li\u003e\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Energy expenditure and thermogenesis, the branch contributed by glucagon\u003c\/li\u003e\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Satiety targeted through four different signals\u003c\/li\u003e\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Body recomposition and fat mass\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eHow it is used\u003c\/p\u003e\n\u003cdiv style=\"display:flex;gap:12px;margin:0 0 1.4em;flex-wrap:wrap;\"\u003e\n  \u003cdiv style=\"flex:1;min-width:150px;padding:12px 16px;background:#f6f6f7;border-radius:10px;\"\u003e\n    \u003cdiv style=\"font-size:.72em;text-transform:uppercase;letter-spacing:.08em;color:#9ca3af;margin-bottom:2px;\"\u003eCycle\u003c\/div\u003e\n    \u003cdiv style=\"font-weight:600;\"\u003eContinuous until target\u003c\/div\u003e\n  \u003c\/div\u003e\n  \u003cdiv style=\"flex:1;min-width:150px;padding:12px 16px;background:#f6f6f7;border-radius:10px;\"\u003e\n    \u003cdiv style=\"font-size:.72em;text-transform:uppercase;letter-spacing:.08em;color:#9ca3af;margin-bottom:2px;\"\u003eBreak\u003c\/div\u003e\n    \u003cdiv style=\"font-weight:600;\"\u003eNot required\u003c\/div\u003e\n  \u003c\/div\u003e\n  \u003cdiv style=\"flex:1;min-width:150px;padding:12px 16px;background:#f6f6f7;border-radius:10px;\"\u003e\n    \u003cdiv style=\"font-size:.72em;text-transform:uppercase;letter-spacing:.08em;color:#9ca3af;margin-bottom:2px;\"\u003eRoute\u003c\/div\u003e\n    \u003cdiv style=\"font-weight:600;\"\u003eWeekly subcutaneous\u003c\/div\u003e\n  \u003c\/div\u003e\n\u003c\/div\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eLyophilized powder with both peptides combined. It is reconstituted with bacteriostatic water, swirled without shaking, and stored between 2 and 8 °C. In the literature the components are administered weekly, always with gradual dose escalation \u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[1]\u003c\/sup\u003e\u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[2]\u003c\/sup\u003e.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eWhat has been observed\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;color:#6b7280;font-size:.95em;\"\u003eResults described in the published scientific literature. They are not directions for use or health recommendations.\u003c\/p\u003e\n\u003cul style=\"margin:0 0 1.2em;padding-left:0;list-style:none;line-height:1.9;\"\u003e\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Retatrutide achieved a mean weight reduction of \u003cstrong\u003e24.2%\u003c\/strong\u003e at 48 weeks in its phase 2 trial, the highest figure published for an incretin agonist \u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[1]\u003c\/sup\u003e\n\u003c\/li\u003e\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Cagrilintide reached 10.8% as monotherapy in its phase 2, and outperformed daily liraglutide despite being injected once a week \u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[2]\u003c\/sup\u003e\n\u003c\/li\u003e\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  That amylin and incretins add up is not a hypothesis: the combination of cagrilintide with semaglutide reached 20.4% in phase 3, above each component separately \u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[3]\u003c\/sup\u003e\n\u003c\/li\u003e\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  For both components, the adverse effects described are mostly digestive, dose-dependent and can be attenuated with slow escalation \u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[1]\u003c\/sup\u003e\u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[2]\u003c\/sup\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eHow it works\u003c\/p\u003e\n\u003cp style=\"margin:1.1em 0 0.3em;font-weight:600;font-family:inherit;\"\u003eRetatrutide — GIP \/ GLP-1 \/ glucagon triple agonist\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eIt acts simultaneously on all three receptors \u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[1]\u003c\/sup\u003e. The GIP and GLP-1 branches reduce intake; the glucagon branch is associated with greater energy expenditure and mobilization of liver fat, and it is what distinguishes it from dual agonists \u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[5]\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp style=\"margin:1.1em 0 0.3em;font-weight:600;font-family:inherit;\"\u003eCagrilintide — amylin analog\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eA long-acting analog designed to resist degradation \u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[4]\u003c\/sup\u003e. It acts on receptors in the area postrema and slows gastric emptying, a pathway independent of incretins \u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[2]\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp style=\"margin:1.1em 0 0.3em;font-weight:600;font-family:inherit;\"\u003eThe rationale for the combination\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eFour targets spread across two systems that do not overlap. The precedent of cagrilintide with semaglutide shows that adding amylin to an incretin agonist produces a greater effect than the incretin agonist alone \u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[3]\u003c\/sup\u003e; this formulation applies the same rationale to a more potent agonist.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eState of the evidence\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.7em;padding:10px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e\u003cstrong\u003eSolid for each component, nonexistent for the combination.\u003c\/strong\u003e Each of the two peptides has published randomized clinical trials \u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[1]\u003c\/sup\u003e\u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[2]\u003c\/sup\u003e, and the principle of combining amylin with an incretin agonist has been validated in phase 3 with another pair \u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[3]\u003c\/sup\u003e. But there is no published study of \u003cem\u003ethis\u003c\/em\u003e specific formulation: it is research material, not a medicine, and its combined profile has not been characterized.\u003c\/p\u003e\n\n\u003cp style=\"margin:1.6em 0 0;padding:12px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e⚠️ Product intended exclusively for \u003cstrong\u003eresearch and laboratory use\u003c\/strong\u003e. Not for human or veterinary consumption.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eReferences\u003c\/p\u003e\n\u003col style=\"margin:0;padding-left:1.4em;font-size:.86em;color:#6b7280;line-height:1.7;\"\u003e\n  \u003cli\u003eJastreboff AM, et al. \u003cem\u003eTriple-Hormone-Receptor Agonist Retatrutide for Obesity - A Phase 2 Trial.\u003c\/em\u003e N Engl J Med, 2023. \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/37366315\/\" target=\"_blank\" rel=\"nofollow noopener\" style=\"color:#0099ff;text-decoration:none;\"\u003ePubMed 37366315\u003c\/a\u003e\n\u003c\/li\u003e\n  \u003cli\u003eLau DCW, et al. \u003cem\u003eOnce-weekly cagrilintide for weight management in people with overweight and obesity: a phase 2 dose-finding trial.\u003c\/em\u003e Lancet, 2021. \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34798060\/\" target=\"_blank\" rel=\"nofollow noopener\" style=\"color:#0099ff;text-decoration:none;\"\u003ePubMed 34798060\u003c\/a\u003e\n\u003c\/li\u003e\n  \u003cli\u003eGarvey WT, et al. \u003cem\u003eCoadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity.\u003c\/em\u003e N Engl J Med, 2025. \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40544433\/\" target=\"_blank\" rel=\"nofollow noopener\" style=\"color:#0099ff;text-decoration:none;\"\u003ePubMed 40544433\u003c\/a\u003e\n\u003c\/li\u003e\n  \u003cli\u003eKruse T, et al. \u003cem\u003eDevelopment of Cagrilintide, a Long-Acting Amylin Analogue.\u003c\/em\u003e J Med Chem, 2021. \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34288673\/\" target=\"_blank\" rel=\"nofollow noopener\" style=\"color:#0099ff;text-decoration:none;\"\u003ePubMed 34288673\u003c\/a\u003e\n\u003c\/li\u003e\n  \u003cli\u003eKatsi V, et al. \u003cem\u003eRetatrutide — A Game Changer in Obesity Pharmacotherapy.\u003c\/em\u003e Biomolecules, 2025. \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40563436\/\" target=\"_blank\" rel=\"nofollow noopener\" style=\"color:#0099ff;text-decoration:none;\"\u003ePubMed 40563436\u003c\/a\u003e\n\u003c\/li\u003e\n\u003c\/ol\u003e","brand":"PeptidoBioGenetic","offers":[{"title":"10 mg","offer_id":55126426878281,"sku":"RC10","price":175.9,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1016\/7507\/3865\/files\/retatrutide-cagrilintide-sin-fondo.png?v=1787687109"},{"product_id":"pack-reconstitucion","title":"Reconstitution Pack","description":"\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:0 0 .4em;font-family:inherit;\"\u003eSummary\u003c\/p\u003e\n\u003cp style=\"font-size:1.05em;line-height:1.65;margin:0 0 1.2em;\"\u003eThe \u003cstrong\u003eReconstitution Pack\u003c\/strong\u003e brings together everything needed to prepare a lyophilized peptide: a vial of \u003cstrong\u003ebacteriostatic water\u003c\/strong\u003e, in 3 ml or 10 ml, and \u003cstrong\u003e10 special painless insulin syringes\u003c\/strong\u003e, 1 ml with an ultra-fine 31G × 6 mm needle.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eWhat's included\u003c\/p\u003e\n\u003cul style=\"margin:0 0 1.2em;padding-left:0;list-style:none;line-height:1.9;\"\u003e\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  1 vial of bacteriostatic water (3 ml or 10 ml, your choice)\u003c\/li\u003e\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  10 insulin syringes of 1 ml, with a 100-unit scale\u003c\/li\u003e\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Special painless needle: 31G gauge and 6 mm long\u003c\/li\u003e\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Fixed needle, no dead space\u003c\/li\u003e\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Single-use syringes, individually packaged\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eWhich size to choose\u003c\/p\u003e\n\u003cdiv style=\"display:flex;gap:12px;margin:0 0 1.4em;flex-wrap:wrap;\"\u003e\n  \u003cdiv style=\"flex:1;min-width:150px;padding:12px 16px;background:#f6f6f7;border-radius:10px;text-align:left;\"\u003e\n    \u003cdiv style=\"font-size:.72em;text-transform:uppercase;letter-spacing:.08em;color:#9ca3af;margin-bottom:2px;\"\u003e3 ml\u003c\/div\u003e\n    \u003cdiv style=\"font-weight:600;\"\u003eFor one vial\u003c\/div\u003e\n  \u003c\/div\u003e\n  \u003cdiv style=\"flex:1;min-width:150px;padding:12px 16px;background:#f6f6f7;border-radius:10px;text-align:left;\"\u003e\n    \u003cdiv style=\"font-size:.72em;text-transform:uppercase;letter-spacing:.08em;color:#9ca3af;margin-bottom:2px;\"\u003e10 ml\u003c\/div\u003e\n    \u003cdiv style=\"font-weight:600;\"\u003eFor several vials or a stack\u003c\/div\u003e\n  \u003c\/div\u003e\n\u003c\/div\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eSpecial painless syringes\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eThe 31G gauge is one of the finest manufactured and the needle is only 6 mm long; that is why they are known as painless: the puncture is barely noticeable. Because the needle is fixed to the barrel, no liquid is retained in the hub, so the measurement shown on the scale is what comes out.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eBacteriostatic water\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eLaboratory-grade sterile water with 0.9% benzyl alcohol, which inhibits bacterial growth and allows the same vial to be accessed multiple times. It is the standard diluent for reconstituting lyophilized peptides.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eProduct use\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eAuxiliary laboratory material for preparing research peptide solutions. At \u003cstrong\u003ePeptido BioGenetic\u003c\/strong\u003e we ship it ready to use, with the water and syringes in the same shipment.\u003c\/p\u003e\n\n\u003cp style=\"margin:1.6em 0 0;padding:12px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e⚠️ Product intended exclusively for \u003cstrong\u003eresearch and laboratory use\u003c\/strong\u003e. Not for human or veterinary consumption.\u003c\/p\u003e","brand":"PeptidoBioGenetic","offers":[{"title":"3 ml","offer_id":55495102267721,"sku":"KIT3","price":15.9,"currency_code":"EUR","in_stock":true},{"title":"10 ml","offer_id":55495102300489,"sku":"KIT10","price":23.9,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1016\/7507\/3865\/files\/pack-reconstitucion-agua-jeringas.png?v=1790959443"},{"product_id":"stack-modo-bestia","title":"STACK MODO BESTIA","description":"\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:0 0 .4em;font-family:inherit;\"\u003eSummary\u003c\/p\u003e\n\u003cp style=\"font-size:1.05em;line-height:1.65;margin:0 0 1.2em;\"\u003e\u003cstrong\u003eModo Bestia\u003c\/strong\u003e is the maximum-build stack: it brings together in a single purchase the four vials used to research \u003cstrong\u003emuscle growth from four angles\u003c\/strong\u003e: preformed growth hormone, stimulation of the hormone your own body produces, cellular energy and tissue repair. It is the highest tier of the three Peptido BioGenetic stacks, designed for those who train seriously: volume, strength and a recovery that keeps up with the pace week after week.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eWhat's included · 4 vials\u003c\/p\u003e\n\u003cdiv style=\"margin:0 0 8px;padding:12px 16px;background:#f6f6f7;border-radius:10px;text-align:left;\"\u003e\n  \u003cdiv style=\"font-size:.72em;text-transform:uppercase;letter-spacing:.08em;color:#9ca3af;margin-bottom:2px;\"\u003eGrowth hormone\u003c\/div\u003e\n  \u003cdiv\u003e\n\u003ca href=\"\/en-us\/products\/hgh-191aa-36-iu\" style=\"color:#0f172a;font-weight:600;text-decoration:none;border-bottom:1px solid rgba(15,23,42,.25);\"\u003eHGH 191AA\u003c\/a\u003e · 36 IU\u003c\/div\u003e\n  \u003cdiv style=\"font-size:.92em;color:#4b5563;line-height:1.5;margin-top:3px;\"\u003ePreformed growth hormone: it supplies the molecule directly, without relying on the pituitary.\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv style=\"margin:0 0 8px;padding:12px 16px;background:#f6f6f7;border-radius:10px;text-align:left;\"\u003e\n  \u003cdiv style=\"font-size:.72em;text-transform:uppercase;letter-spacing:.08em;color:#9ca3af;margin-bottom:2px;\"\u003eSecretagogue\u003c\/div\u003e\n  \u003cdiv\u003e\n\u003ca href=\"\/en-us\/products\/cjc-1295-ipamorelin-20-mg\" style=\"color:#0f172a;font-weight:600;text-decoration:none;border-bottom:1px solid rgba(15,23,42,.25);\"\u003eCJC-1295 + Ipamorelin\u003c\/a\u003e · 20 mg\u003c\/div\u003e\n  \u003cdiv style=\"font-size:.92em;color:#4b5563;line-height:1.5;margin-top:3px;\"\u003eStimulates the pituitary to release its own growth hormone, in pulses.\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv style=\"margin:0 0 8px;padding:12px 16px;background:#f6f6f7;border-radius:10px;text-align:left;\"\u003e\n  \u003cdiv style=\"font-size:.72em;text-transform:uppercase;letter-spacing:.08em;color:#9ca3af;margin-bottom:2px;\"\u003eMitochondrial\u003c\/div\u003e\n  \u003cdiv\u003e\n\u003ca href=\"\/en-us\/products\/mots-c-20-mg\" style=\"color:#0f172a;font-weight:600;text-decoration:none;border-bottom:1px solid rgba(15,23,42,.25);\"\u003eMOTS-c\u003c\/a\u003e · 40 mg\u003c\/div\u003e\n  \u003cdiv style=\"font-size:.92em;color:#4b5563;line-height:1.5;margin-top:3px;\"\u003eMitochondrial peptide: the cellular energy to train at that pace.\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv style=\"margin:0 0 8px;padding:12px 16px;background:#f6f6f7;border-radius:10px;text-align:left;\"\u003e\n  \u003cdiv style=\"font-size:.72em;text-transform:uppercase;letter-spacing:.08em;color:#9ca3af;margin-bottom:2px;\"\u003eRepair\u003c\/div\u003e\n  \u003cdiv\u003e\n\u003ca href=\"\/en-us\/products\/klow-blend-80-mg\" style=\"color:#0f172a;font-weight:600;text-decoration:none;border-bottom:1px solid rgba(15,23,42,.25);\"\u003eKLOW\u003c\/a\u003e · 80 mg\u003c\/div\u003e\n  \u003cdiv style=\"font-size:.92em;color:#4b5563;line-height:1.5;margin-top:3px;\"\u003eFour repair peptides in one vial (BPC-157, GHK-Cu, TB-500 and KPV) for the tissue that bears the load.\u003c\/div\u003e\n\u003c\/div\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eWhat is it researched for?\u003c\/p\u003e\n\u003cul style=\"margin:0 0 1.2em;padding-left:0;list-style:none;line-height:1.9;\"\u003e\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Muscle mass gain\u003c\/li\u003e\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Strength\u003c\/li\u003e\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Recovery between sessions\u003c\/li\u003e\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Deep sleep\u003c\/li\u003e\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Body composition: less fat\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eWhy they work together\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003e\u003cstrong\u003eHGH 191AA\u003c\/strong\u003e is preformed growth hormone and acts from day one. \u003cstrong\u003eCJC-1295 + Ipamorelin\u003c\/strong\u003e work from the other side: they stimulate the pituitary to release the hormone your body produces, in natural pulses and especially during sleep. Between the two, they cover the growth hormone axis day and night. \u003cstrong\u003eMOTS-c\u003c\/strong\u003e provides the cellular energy to train, and \u003cstrong\u003eKLOW\u003c\/strong\u003e repairs the tissue that bears the load.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eFree with your stack\u003c\/p\u003e\n\u003cdiv style=\"margin:0 0 8px;padding:12px 16px;background:#f6f6f7;border-radius:10px;text-align:left;\"\u003e\n  \u003cdiv style=\"font-weight:600;\"\u003eReconstitution pack\u003c\/div\u003e\n  \u003cdiv style=\"font-size:.92em;color:#4b5563;line-height:1.5;margin-top:3px;\"\u003eBacteriostatic water 10 ml + 10 insulin syringes 31G × 6 mm. Everything needed to reconstitute the 4 vials, at no cost: it is added to the cart together with the stack.\u003c\/div\u003e\n\u003c\/div\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eAnd when you reorder\u003c\/p\u003e\n\u003cdiv style=\"margin:0 0 8px;padding:12px 16px;background:#f6f6f7;border-radius:10px;text-align:left;\"\u003e\n  \u003cdiv style=\"font-weight:600;\"\u003e15% off and free shipping on your next order\u003c\/div\u003e\n  \u003cdiv style=\"font-size:.92em;color:#4b5563;line-height:1.5;margin-top:3px;\"\u003eYou receive the code with your stack. Valid for any product in the catalog, once per customer.\u003c\/div\u003e\n\u003c\/div\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eCycle and break\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eEach vial follows its own cycle. The application schedule for each one is calculated separately in the \u003ca href=\"\/en-us\/pages\/calculadora\" style=\"color:#0f172a;font-weight:600;text-decoration:none;border-bottom:1px solid rgba(15,23,42,.25);\"\u003eCalculator\u003c\/a\u003e.\u003c\/p\u003e\n\u003cdiv style=\"margin:0 0 8px;padding:12px 16px;background:#f6f6f7;border-radius:10px;text-align:left;display:flex;gap:12px;flex-wrap:wrap;align-items:baseline;\"\u003e\n  \u003cdiv style=\"flex:1.4;min-width:130px;font-weight:600;\"\u003eHGH 191AA\u003c\/div\u003e\n  \u003cdiv style=\"flex:1;min-width:95px;\"\u003e\n\u003cspan style=\"font-size:.72em;text-transform:uppercase;letter-spacing:.08em;color:#9ca3af;margin-bottom:2px;display:block;\"\u003eCycle\u003c\/span\u003e12–24 weeks\u003c\/div\u003e\n  \u003cdiv style=\"flex:1;min-width:95px;\"\u003e\n\u003cspan style=\"font-size:.72em;text-transform:uppercase;letter-spacing:.08em;color:#9ca3af;margin-bottom:2px;display:block;\"\u003eBreak\u003c\/span\u003e6–8 weeks\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv style=\"margin:0 0 8px;padding:12px 16px;background:#f6f6f7;border-radius:10px;text-align:left;display:flex;gap:12px;flex-wrap:wrap;align-items:baseline;\"\u003e\n  \u003cdiv style=\"flex:1.4;min-width:130px;font-weight:600;\"\u003eCJC-1295 + Ipamorelin\u003c\/div\u003e\n  \u003cdiv style=\"flex:1;min-width:95px;\"\u003e\n\u003cspan style=\"font-size:.72em;text-transform:uppercase;letter-spacing:.08em;color:#9ca3af;margin-bottom:2px;display:block;\"\u003eCycle\u003c\/span\u003e8–12 weeks\u003c\/div\u003e\n  \u003cdiv style=\"flex:1;min-width:95px;\"\u003e\n\u003cspan style=\"font-size:.72em;text-transform:uppercase;letter-spacing:.08em;color:#9ca3af;margin-bottom:2px;display:block;\"\u003eBreak\u003c\/span\u003e4 weeks\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv style=\"margin:0 0 8px;padding:12px 16px;background:#f6f6f7;border-radius:10px;text-align:left;display:flex;gap:12px;flex-wrap:wrap;align-items:baseline;\"\u003e\n  \u003cdiv style=\"flex:1.4;min-width:130px;font-weight:600;\"\u003eMOTS-c\u003c\/div\u003e\n  \u003cdiv style=\"flex:1;min-width:95px;\"\u003e\n\u003cspan style=\"font-size:.72em;text-transform:uppercase;letter-spacing:.08em;color:#9ca3af;margin-bottom:2px;display:block;\"\u003eCycle\u003c\/span\u003e4–6 weeks\u003c\/div\u003e\n  \u003cdiv style=\"flex:1;min-width:95px;\"\u003e\n\u003cspan style=\"font-size:.72em;text-transform:uppercase;letter-spacing:.08em;color:#9ca3af;margin-bottom:2px;display:block;\"\u003eBreak\u003c\/span\u003e4 weeks\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv style=\"margin:0 0 8px;padding:12px 16px;background:#f6f6f7;border-radius:10px;text-align:left;display:flex;gap:12px;flex-wrap:wrap;align-items:baseline;\"\u003e\n  \u003cdiv style=\"flex:1.4;min-width:130px;font-weight:600;\"\u003eKLOW\u003c\/div\u003e\n  \u003cdiv style=\"flex:1;min-width:95px;\"\u003e\n\u003cspan style=\"font-size:.72em;text-transform:uppercase;letter-spacing:.08em;color:#9ca3af;margin-bottom:2px;display:block;\"\u003eCycle\u003c\/span\u003e20–30 days\u003c\/div\u003e\n  \u003cdiv style=\"flex:1;min-width:95px;\"\u003e\n\u003cspan style=\"font-size:.72em;text-transform:uppercase;letter-spacing:.08em;color:#9ca3af;margin-bottom:2px;display:block;\"\u003eBreak\u003c\/span\u003e3–4 months\u003c\/div\u003e\n\u003c\/div\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eScientific evidence\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.7em;padding:10px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e\u003cstrong\u003eHGH 191AA:\u003c\/strong\u003e Recombinant somatropin is one of the best-described proteins in modern pharmacology, in clinical use since the 1980s, and the relationship between exogenous GH and circulating IGF-1 is documented in detail.\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.7em;padding:10px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e\u003cstrong\u003eCJC-1295 + Ipamorelin:\u003c\/strong\u003e Studies with the GRF(1-29) fragment document dose-dependent increases in GH and IGF-1 in healthy subjects; Ipamorelin is described as the most selective secretagogue in its family.\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.7em;padding:10px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e\u003cstrong\u003eMOTS-c:\u003c\/strong\u003e Improvements in insulin sensitivity and glucose metabolism have been described, with effects that replicate those of exercise; its translocation from the mitochondria to the nucleus has been documented since 2015 (Lee et al.).\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.7em;padding:10px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e\u003cstrong\u003eKLOW:\u003c\/strong\u003e In preclinical studies, BPC-157 accelerates healing of tendon, muscle and bone, and GHK-Cu increases collagen synthesis in wound models; human data for each component are limited.\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.7em;padding:10px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e\u003cstrong\u003eAn honest note:\u003c\/strong\u003e the available evidence is that of each component separately. There are no controlled human studies of this specific combination.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eProduct use\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eThe stack brings together 4 complementary reference materials for research on the somatotropic axis, energy metabolism and tissue repair. At \u003cstrong\u003ePeptido BioGenetic\u003c\/strong\u003e each vial is supplied with high-purity components and a certificate of analysis (COA) available on request.\u003c\/p\u003e\n\n\u003cp style=\"margin:1.6em 0 0;padding:12px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e⚠️ Product intended exclusively for \u003cstrong\u003eresearch and laboratory use\u003c\/strong\u003e. Not for human or veterinary consumption.\u003c\/p\u003e","brand":"PeptidoBioGenetic","offers":[{"title":"Default Title","offer_id":55495104528713,"sku":"STK1","price":699.9,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1016\/7507\/3865\/files\/stack-modo-bestia-viales.png?v=1790959502"}],"url":"https:\/\/www.peptidobiogenetic.com\/en-us\/collections\/all.oembed","provider":"PeptidoBioGenetic","version":"1.0","type":"link"}